###begin article-title 0
Sideromycins: tools and antibiotics
###end article-title 0
###begin p 1
###xml 880 881 880 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1223 1239 1223 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 1244 1268 1244 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pneumoniae</italic>
###xml 1276 1297 1276 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 1401 1424 1401 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica</italic>
###xml 1426 1439 1426 1439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pneumoniae</italic>
###xml 1445 1454 1445 1454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 1223 1239 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1244 1268 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 1276 1297 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 1383 1388 <span type="species:ncbi:10090">mouse</span>
###xml 1401 1424 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 1426 1439 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 1445 1454 <span type="species:ncbi:1280">S. aureus</span>
Sideromycins are antibiotics covalently linked to siderophores. They are actively transported into gram-positive and gram-negative bacteria. Energy-coupled transport across the outer membrane and the cytoplasmic membrane strongly increases their antibiotic efficiency; their minimal inhibitory concentration is at least 100-fold lower than that of antibiotics that enter cells by diffusion. This is particularly relevant for gram-negative bacteria because the outer membrane, which usually forms a permeability barrier, in this case actively contributes to the uptake of sideromycins. Sideromycin-resistant mutants can be used to identify siderophore transport systems since the mutations are usually in transport genes. Two sideromycins, albomycin and salmycin, are discussed here. Albomycin, a derivative of ferrichrome with a bound thioribosyl-pyrimidine moiety, inhibts seryl-t-RNA synthetase. Salmycin, a ferrioxamine derivative with a bound aminodisaccharide, presumably inhibts protein synthesis. Crystal structures of albomycin bound to the outer membrane transporter FhuA and the periplasmic binding protein FhuD have been determined. Albomycin and salmycin have been used to characterize the transport systems of Escherichia coli and Streptococcus pneumoniae and of Staphylococcus aureus, respectively. The in vivo efficacy of albomycin and salmycin has been examined in a mouse model using Yersinia enterocolitica, S. pneumoniae, and S. aureus infections. Albomycin is effective in clearing infections, whereas salmycin is too unstable to lead to a large reduction in bacterial numbers. The recovery rate of albomycin-resistant mutants is lower than that of the wild-type, which suggests a reduced fitness of the mutants. Albomycin could be a useful antibiotic provided sufficient quantities can be isolated from streptomycetes or synthesized chemically.
###end p 1
###begin title 2
Keywords
###end title 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 143 145 143 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 296 298 296 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 332 334 332 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 435 437 435 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 524 526 524 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 633 635 633 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
Iron, an essential element, is contained in active centers of many redox enzymes. Under oxic conditions, it occurs in nature as an insoluble Fe3+ hydroxide polymer and in eukaryotic hosts tightly bound to transferrin and lactoferrin. However, bacterial and fungal siderophores, with their high Fe3+ specificity and affinity, make Fe3+ available. The microorganisms synthesize and secrete the siderophores, which are then taken up as Fe3+-complexes via specific active transport systems. Gram-negative bacteria concentrate Fe3+-siderophores at the cell surface by binding them to very specific high-affinity transport proteins. The Fe3+-siderophores are then transported across the outer membrane into the periplasm and from there across the cytoplasmic membrane into the cytoplasm, where iron is released from the siderophores and incorporated into heme and non-heme iron proteins.
###end p 4
###begin p 5
###xml 58 60 58 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">1967</xref>
The term sideromycin was coined for naturally occurring Fe3+-siderophores that are covalently linked to an antibiotic moiety. Sideromycins were actually discovered prior to siderophores in a sceening for new antibiotics and were originally called sideramines or siderochromes (Nuesch and Knusel 1967). Siderophores were later found to antagonize the activity of sideromycins, and it was initially assumed that the siderophores competed with the sideromycins at the sideromycin target sites. It was then shown that siderophores and sideromycins compete for common uptake systems.
###end p 5
###begin title 6
###xml 31 33 31 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
Sideromycins are taken up by Fe3+-siderophore transport systems
###end title 6
###begin p 7
###xml 70 72 70 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 334 338 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">2005</xref>
###xml 359 363 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">2008</xref>
###xml 372 376 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">2008</xref>
###xml 455 457 449 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 490 491 484 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 490 491 484 485 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>D</italic></sub>
Crystal structures of the proteins responsible for the transport of Fe3+-siderophores across the outer membrane have been determined. The various proteins are similar in structure and consist of 22 beta strands that form beta barrels with an internal pore completely closed by a globular domain, called the plug (summarized by Wiener 2005; Krewulak and Vogel 2008; Schalk 2008). Up to ten amino acid residues at the surface of the transporters bind the Fe3+-siderophores very tightly with KD values in the range of 1 nM.
###end p 7
###begin p 8
###xml 51 53 51 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 442 443 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 835 836 829 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1230 1234 1224 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">1987</xref>
###xml 1363 1367 1357 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">1999</xref>
###xml 1550 1552 1544 1546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 1637 1639 1631 1633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 1672 1678 1666 1672 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 1724 1731 1718 1725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 2242 2245 2236 2239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 2257 2262 2251 2256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 2427 2437 2415 2425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue-green</italic>
###xml 2476 2482 2464 2470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yellow</italic>
###xml 1678 2654 1672 2639 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="9">Albomycin and ferrichrome transport system of <italic>E. coli</italic>. Both compounds are transported by the same proteins: FhuA in the outer membrane, FhuD in the periplasm, and FhuB in the cytoplasmic membrane. FhuC is the ATPase that provides the energy for transport across the cytoplasmic membrane. The proteins TonB, ExbB, and ExbD form a complex that provides energy for transport across the outer membrane. The transmembrane topology of the cytoplasmic membrane proteins but not the stoichiometry of TonB, ExbB, and ExbD is shown. The complete crystal structures of FhuA (<italic>red</italic>) and FhuD (<italic>green</italic>) loaded with albomycin and the crystal structures of periplasmic portions of TonB and ExbD are shown. The 22 anti-parallel &#946;-strands of FhuA form a &#946;-barrel (<italic>blue-green</italic>) that is closed by a globular domain (<italic>yellow</italic>). The TonB box of FhuA forms with TonB a four-stranded &#946;-sheet. The structure of the linkage between the membrane segment and the crystallized domain of TonB is unknown</p>
###xml 1678 2654 1672 2639 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="9">Albomycin and ferrichrome transport system of <italic>E. coli</italic>. Both compounds are transported by the same proteins: FhuA in the outer membrane, FhuD in the periplasm, and FhuB in the cytoplasmic membrane. FhuC is the ATPase that provides the energy for transport across the cytoplasmic membrane. The proteins TonB, ExbB, and ExbD form a complex that provides energy for transport across the outer membrane. The transmembrane topology of the cytoplasmic membrane proteins but not the stoichiometry of TonB, ExbB, and ExbD is shown. The complete crystal structures of FhuA (<italic>red</italic>) and FhuD (<italic>green</italic>) loaded with albomycin and the crystal structures of periplasmic portions of TonB and ExbD are shown. The 22 anti-parallel &#946;-strands of FhuA form a &#946;-barrel (<italic>blue-green</italic>) that is closed by a globular domain (<italic>yellow</italic>). The TonB box of FhuA forms with TonB a four-stranded &#946;-sheet. The structure of the linkage between the membrane segment and the crystallized domain of TonB is unknown</p></caption>
###xml 2654 2654 2639 2639 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10534_2008_9199_Fig1_HTML" id="MO1"/>
###xml 1672 2654 1666 2639 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="9">Albomycin and ferrichrome transport system of <italic>E. coli</italic>. Both compounds are transported by the same proteins: FhuA in the outer membrane, FhuD in the periplasm, and FhuB in the cytoplasmic membrane. FhuC is the ATPase that provides the energy for transport across the cytoplasmic membrane. The proteins TonB, ExbB, and ExbD form a complex that provides energy for transport across the outer membrane. The transmembrane topology of the cytoplasmic membrane proteins but not the stoichiometry of TonB, ExbB, and ExbD is shown. The complete crystal structures of FhuA (<italic>red</italic>) and FhuD (<italic>green</italic>) loaded with albomycin and the crystal structures of periplasmic portions of TonB and ExbD are shown. The 22 anti-parallel &#946;-strands of FhuA form a &#946;-barrel (<italic>blue-green</italic>) that is closed by a globular domain (<italic>yellow</italic>). The TonB box of FhuA forms with TonB a four-stranded &#946;-sheet. The structure of the linkage between the membrane segment and the crystallized domain of TonB is unknown</p></caption><graphic position="anchor" xlink:href="10534_2008_9199_Fig1_HTML" id="MO1"/></fig>
###xml 1724 1731 <span type="species:ncbi:562">E. coli</span>
Structural transitions must occur to release the Fe3+-siderophores and to move the plugs to open the pores. Both processes require energy, which is not available in the outer membrane. Energy is provided by the proton-motive force of the cytoplasmic membrane and is transduced from there to the outer membrane by the Ton protein complex, consisting of TonB, ExbB, and ExbD. These three proteins are embedded in the cytoplasmic membrane (Fig. 1). The stoichiometry of the TonB:ExbB:ExbD proteins in cells, but not necessarily in the complex, is 1:7:2. TonB interacts with the outer membrane transport proteins, as has been revealed by genetic, biochemical, and protein crystallographic methods. The C-proximal end of TonB forms a three-stranded beta-sheet, to which the beta-strand of the N-terminal end of the transporters binds (Fig. 1). Prior to the crystallographic proof of binding, the N-terminal end was presumed to bind to TonB based on various pieces of evidence: sequence similarities among transporters, mutations that inactivate the transporters, and suppressor mutations in the C-proximal end of TonB that restore the activity of the TonB box mutants. This region was therefore designated the TonB box (Schramm et al. 1987). The Ton complex responds to the proton-motive force by altering the confirmation of TonB to its energized form (Larsen et al. 1999). It is assumed that interaction of the energized form with the outer membrane transporters then alters the conformation of the transporters, resulting in the release of the bound Fe3+-siderophores, the opening of a pore in the transporters, and the diffusion of the Fe3+-siderophores into the periplasm.Fig. 1Albomycin and ferrichrome transport system of E. coli. Both compounds are transported by the same proteins: FhuA in the outer membrane, FhuD in the periplasm, and FhuB in the cytoplasmic membrane. FhuC is the ATPase that provides the energy for transport across the cytoplasmic membrane. The proteins TonB, ExbB, and ExbD form a complex that provides energy for transport across the outer membrane. The transmembrane topology of the cytoplasmic membrane proteins but not the stoichiometry of TonB, ExbB, and ExbD is shown. The complete crystal structures of FhuA (red) and FhuD (green) loaded with albomycin and the crystal structures of periplasmic portions of TonB and ExbD are shown. The 22 anti-parallel beta-strands of FhuA form a beta-barrel (blue-green) that is closed by a globular domain (yellow). The TonB box of FhuA forms with TonB a four-stranded beta-sheet. The structure of the linkage between the membrane segment and the crystallized domain of TonB is unknown
###end p 8
###begin p 9
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 564 567 564 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 579 584 579 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 749 759 743 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue-green</italic>
###xml 798 804 792 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yellow</italic>
###xml 46 53 <span type="species:ncbi:562">E. coli</span>
Albomycin and ferrichrome transport system of E. coli. Both compounds are transported by the same proteins: FhuA in the outer membrane, FhuD in the periplasm, and FhuB in the cytoplasmic membrane. FhuC is the ATPase that provides the energy for transport across the cytoplasmic membrane. The proteins TonB, ExbB, and ExbD form a complex that provides energy for transport across the outer membrane. The transmembrane topology of the cytoplasmic membrane proteins but not the stoichiometry of TonB, ExbB, and ExbD is shown. The complete crystal structures of FhuA (red) and FhuD (green) loaded with albomycin and the crystal structures of periplasmic portions of TonB and ExbD are shown. The 22 anti-parallel beta-strands of FhuA form a beta-barrel (blue-green) that is closed by a globular domain (yellow). The TonB box of FhuA forms with TonB a four-stranded beta-sheet. The structure of the linkage between the membrane segment and the crystallized domain of TonB is unknown
###end p 9
###begin p 10
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 427 429 427 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 500 502 500 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 917 921 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">2001</xref>
###xml 1239 1240 1239 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1242 1248 1242 1248 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 1436 1437 1436 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1248 1438 1248 1438 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="11">Chemical structures of ferrichrome, albomycin, ferrioxamine B, and salmycin. The co-crystals of ferrichrome and albomycin with FhuA reveal their structures in the protein-bound form (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>)</p>
###xml 1248 1438 1248 1438 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="11">Chemical structures of ferrichrome, albomycin, ferrioxamine B, and salmycin. The co-crystals of ferrichrome and albomycin with FhuA reveal their structures in the protein-bound form (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>)</p></caption>
###xml 1438 1438 1438 1438 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10534_2008_9199_Fig2_HTML" id="MO2"/>
###xml 1242 1438 1242 1438 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="11">Chemical structures of ferrichrome, albomycin, ferrioxamine B, and salmycin. The co-crystals of ferrichrome and albomycin with FhuA reveal their structures in the protein-bound form (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>)</p></caption><graphic position="anchor" xlink:href="10534_2008_9199_Fig2_HTML" id="MO2"/></fig>
Only a few naturally occurring sideromycins have been found, among them albomycin and salmycin (Fig. 2). A wide spectrum of siderophore-antibiotic conjugates have been chemically synthesized. Although the antibiotic moieties account for a substantial part of the sideromycins and drastically change the shape of the siderophore from which they are derived, the sideromycins are nevertheless recognized and transported by the Fe3+-siderophore transport proteins. The transport proteins identify the Fe3+-complexes and tolerate additions to an astounding degree. It seems that whatever is bound to the active site of the transport proteins is also transported. The most extreme case is the transport of a rifamycin derivative, designated CGP 4832, by the FhuA outer membrane transporter-CGP 4832 in the crystal structure with FhuA shows no structural similarity with ferrichrome, the substrate of FhuA (Ferguson et al. 2001). Of the ten amino acid residues of FhuA that bind ferricrocin, a derivative of ferrichrome, nine also bind CGP 4832. The rifamycin derivative, however, is not transported across the cytoplasmic membrane, probably because it is not recognized by the FhuBD proteins that transport ferrichrome into the cytoplasm (Fig. 1).Fig. 2Chemical structures of ferrichrome, albomycin, ferrioxamine B, and salmycin. The co-crystals of ferrichrome and albomycin with FhuA reveal their structures in the protein-bound form (Fig. 1)
###end p 10
###begin p 11
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
Chemical structures of ferrichrome, albomycin, ferrioxamine B, and salmycin. The co-crystals of ferrichrome and albomycin with FhuA reveal their structures in the protein-bound form (Fig. 1)
###end p 11
###begin title 12
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 28 35 <span type="species:ncbi:562">E. coli</span>
Transport of albomycin into E. coli
###end title 12
###begin p 13
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 203 210 203 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 254 256 254 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pepN</italic>
###xml 380 384 380 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pepN</italic>
###xml 603 607 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">1979</xref>
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">1983</xref>
###xml 203 210 <span type="species:ncbi:562">E. coli</span>
Among the sideromycins, albomycin has been studied in most detail. Albomycin consists of a siderophore structurally similar to ferrichrome with a bound thioribosyl pyrimidine antibiotic (Fig. 2). Inside E. coli cells, the antibiotic is cleaved off the Fe3+ carrier by peptidase N, encoded by pepN. The antibiotic stays inside the cells, whereas the iron-free carrier is excreted. pepN mutants are albomycin resistant; therefore, release of the antibiotic from the carrier is required for activity. Without cleavage, albomycin functions only as a siderophore and carries iron into cells (Hartmann et al. 1979; Braun et al. 1983).
###end p 13
###begin p 14
###xml 117 124 117 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 342 346 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">2000</xref>
###xml 117 124 <span type="species:ncbi:562">E. coli</span>
Albomycin is taken up via the ferrichrome transport system across the outer membrane and the cytoplasmic membrane of E. coli and other gram-negative bacteria. It binds to FhuA well above the surface of cells. It assumes two different conformations in the FhuA-albomycin crystal structure: an extended form and a compact form (Ferguson et al. 2000). The extended form has the same ten amino acid binding sites as ferrichrome. Four additional residues bind the antibiotic.
###end p 14
###begin p 15
###xml 115 116 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 235 239 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">1995</xref>
###xml 497 501 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">1995</xref>
###xml 1031 1035 1020 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">2005</xref>
After the FhuA- and Ton-dependent uptake across the outer membrane, albomycin binds to FhuD in the periplasm (Fig. 1). Albomycin and ferrichrome bound to FhuD have dissociation constants of 5.4 and 1 muM, respectively (Rohrbach et al. 1995). FhuD then delivers albomycin to FhuB. FhuD binds to FhuB in this process, as indicated by chemical cross-linking of substrate-loaded as well as unloaded FhuD to FhuB and the prevention of FhuB proteolysis when FhuB is incubated with FhuD (Rohrbach et al. 1995). The two independently folded domains of FhuD are connected by an alpha-helix that confers rigidity to the molecule. The large movement of the two domains upon substrate binding and release observed in most other periplasmic binding proteins (Venus flytrap-like fashion) does not occur in FhuD. A molecular dynamics simulation has revealed a closure of 6degrees of a C-terminal domain upon release of the siderophore; this movement seems to be sufficient for the distinction of unloaded and loaded FhuD by FhuB (Krewulak et al. 2005).
###end p 15
###begin p 16
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">1998</xref>
###xml 365 369 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">1992</xref>
###xml 633 637 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">2008</xref>
In contrast to most dimeric ABC transport proteins in the cytoplasmic membrane, FhuB consists of a single polypeptide with 12 transmembrane segments (Groeger and Koster 1998). The N- and C-terminal halves are homologous. FhuB point mutations in regions conserved among ABC transporters confer albomycin resistance and lack of ferrichrome transport (Koster and Bohm 1992). It is not known whether there is specific albomycin binding to FhuB in the cytoplasmic membrane. In this and other ABC import systems, substrate specificity is primarily determined by binding of the substrate to the periplasmic binding protein (Davidson et al. 2008). Binding of substrate-loaded FhuD to FhuB presumably opens a channel in FhuB and triggers ATP hydrolysis by FhuC.
###end p 16
###begin p 17
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">1992</xref>
FhuC is a typical NBD protein (ATPase), as found in other ABC transporters. Mutations in predicted ATP binding sites inactivate FhuC, abolish ferrichrome transport, and confer albomycin resistance (Schultz-Hauser et al. 1992).
###end p 17
###begin p 18
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">2007</xref>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">2008</xref>
###xml 1052 1053 1048 1049 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
Comparison of the crystal structures of four ABC transporters (Hollenstein et al. 2007) and biochemical studies of ABC transporters reconstituted in liposomes (Davidson et al. 2008) reveal the following common features, which might also apply to ferrichrome and albomycin transport via FhuBCD. The channel in the cytoplasmic membrane is formed by 12 alpha-helices. They assume an outward-facing or inward-facing conformation. Unidirectional transport is achieved by the ATP-driven conversion of the inward-facing state to the outward-facing state. Binding of two ATP molecules at the interface between the two nucleotide-binding domains (ATPases) closes the gap between the two ATP-binding sites and also causes closure of the helices that bind to the two NBD molecules. The helices flip from the inward-facing to the outward-facing conformation. This structural transition might be transmitted to the substrate-loaded binding protein, which opens and releases the substrate to the inner membrane transporter. ATP hydrolysis and dissociation of ADP + Pi from the ABC transporter reset the inward-facing conformation, allowing the substrate to enter the cytoplasm.
###end p 18
###begin title 19
###xml 41 65 41 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pneumoniae</italic>
###xml 70 91 70 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 41 65 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 70 91 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Transport of albomycin and salmycin into Streptococcus pneumoniae and Staphylococcus aureus
###end title 19
###begin p 20
###xml 136 149 136 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pneumoniae</italic>
###xml 154 163 154 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 136 149 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 154 163 <span type="species:ncbi:1280">S. aureus</span>
Since salmycin inhibits almost exclusively gram-positive bacteria (see below), uptake of salmycin has been studied in the gram-positive S. pneumoniae and S. aureus. Mutants of both organisms display cross-resistance to salmycin and albomycin, and ferrichrome and ferrioxamine B inhibit the toxicity of both antibiotics. These results indicate that salmycin and albomycin are taken up by the same transport system.
###end p 20
###begin p 21
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">1995</xref>
###xml 486 509 486 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus peumoniae</italic>
###xml 574 583 574 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 574 583 <span type="species:ncbi:1280">S. aureus</span>
The target site of albomycin is known, but that of salmycin is not. Salmycin consists of a ferrioxamine B derivative (danoxamine) and an aminodisaccharide (Vertesy et al. 1995). It inhibits an unidentified step of protein synthesis. Target-site mutants common to albomycin and salmycin cannot be isolated because the completely different antibiotics exclude the same toxicity mechanism. Since albomycin is more readily available, mostly it has been used to isolate transport mutants of Streptococcus peumoniae and to characterize the mutated genes and their products. A few S. aureus mutants have been selected with salmycin (Gwinner and Braun, unpublished results).
###end p 21
###begin p 22
###xml 54 67 54 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pneumoniae</italic>
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2002</xref>
###xml 319 332 319 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pneumoniae</italic>
###xml 602 606 602 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">2006</xref>
###xml 682 683 682 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 796 800 796 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuB</italic>
###xml 802 806 802 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuD</italic>
###xml 812 816 812 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuG</italic>
###xml 948 950 948 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 1018 1020 1018 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1022 1024 1022 1024 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 1055 1057 1055 1057 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1059 1061 1059 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 1135 1137 1135 1137 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 1392 1396 1392 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">2006</xref>
###xml 1425 1438 1425 1438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pneumoniae</italic>
###xml 1465 1467 1465 1467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 1633 1639 1633 1639 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 1658 1661 1658 1661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhu</italic>
###xml 1685 1698 1685 1698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pneumoniae</italic>
###xml 1703 1712 1703 1712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 1818 1826 1818 1826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">negative</italic>
###xml 1826 1832 1826 1832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">number</italic>
###xml 1639 1865 1639 1865 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="23">Arrangement of the <italic>fhu</italic> genes on the genome of <italic>S. pneumoniae</italic> and <italic>S. aureus</italic>. The number of nucleotides (nt, nucleotides; mnt, million nucleotides) between the genes is indicated; a <italic>negative</italic><italic>number</italic> indicates that the genes overlap</p>
###xml 1639 1865 1639 1865 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="23">Arrangement of the <italic>fhu</italic> genes on the genome of <italic>S. pneumoniae</italic> and <italic>S. aureus</italic>. The number of nucleotides (nt, nucleotides; mnt, million nucleotides) between the genes is indicated; a <italic>negative</italic><italic>number</italic> indicates that the genes overlap</p></caption>
###xml 1865 1865 1865 1865 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10534_2008_9199_Fig3_HTML" id="MO3"/>
###xml 1633 1865 1633 1865 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="23">Arrangement of the <italic>fhu</italic> genes on the genome of <italic>S. pneumoniae</italic> and <italic>S. aureus</italic>. The number of nucleotides (nt, nucleotides; mnt, million nucleotides) between the genes is indicated; a <italic>negative</italic><italic>number</italic> indicates that the genes overlap</p></caption><graphic position="anchor" xlink:href="10534_2008_9199_Fig3_HTML" id="MO3"/></fig>
###xml 54 67 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 319 332 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 1425 1438 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 1685 1698 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 1703 1712 <span type="species:ncbi:1280">S. aureus</span>
Several iron transport systems have been predicted in S. pneumoniae based on comparison of its genome sequence with other genome sequences (Brown et al. 2002). These systems have been shown experimentally to be related to iron transport, but siderophores have not been identified. The identification of siderophores in S. pneumoniae is difficult because the bacterium only grows on complex media, such as blood agar. The use of sideromycins circumvents this problem since resistant mutants can be isolated on complex media and these mutants usually have modified transport proteins (Pramanik and Braun 2006). Using this approach, the albomycin transport genes were identified (Fig. 3). Additional mutants were isolated by transposon mutagenesis and insertion duplication mutagenesis. Chromosomal fhuB, fhuD, and fhuG mutants were isolated. The transport defects were verified by comparing growth promotion of the wild-type and the mutants by the Fe3+-hydroxamates and by comparing the transport rates of radiolabeled [55Fe3+]ferrichrome and radiolabeled [55Fe3+]ferrioxamine B of the wild-type with that of mutants. In addition, the Fe3+-hydroxamates cross-streaked on nutrient agar with the antibiotics interfered with growth inhibition of the antibiotics. The FhuD binding protein has been isolated and shown to bind ferrichrome, ferrioxamine B, albomycin, and salmycin (Pramanik and Braun 2006). This study shows that the S. pneumoniae genome encodes a single Fe3+-hydroxamate transport system, through which ferrichrome, ferrioxamine B, and the structurally related antibiotics albomycin and salmycin are taken up into the cells.Fig. 3Arrangement of the fhu genes on the genome of S. pneumoniae and S. aureus. The number of nucleotides (nt, nucleotides; mnt, million nucleotides) between the genes is indicated; a negativenumber indicates that the genes overlap
###end p 22
###begin p 23
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhu</italic>
###xml 46 59 46 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pneumoniae</italic>
###xml 64 73 64 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 179 187 179 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">negative</italic>
###xml 187 193 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">number</italic>
###xml 46 59 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 64 73 <span type="species:ncbi:1280">S. aureus</span>
Arrangement of the fhu genes on the genome of S. pneumoniae and S. aureus. The number of nucleotides (nt, nucleotides; mnt, million nucleotides) between the genes is indicated; a negativenumber indicates that the genes overlap
###end p 23
###begin p 24
###xml 24 33 24 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 40 42 40 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">2003</xref>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">2006</xref>
###xml 157 166 157 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 224 226 224 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 358 360 358 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 404 407 404 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 572 581 570 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 595 599 593 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuD</italic>
###xml 642 648 640 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuBCG</italic>
###xml 661 662 659 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 670 674 668 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuD</italic>
###xml 797 802 795 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuD1</italic>
###xml 933 938 931 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuD2</italic>
###xml 1220 1231 1218 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuD1 fhuD2</italic>
###xml 1312 1317 1310 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuD2</italic>
###xml 1396 1401 1394 1399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuD1</italic>
###xml 1509 1514 1507 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuD1</italic>
###xml 1549 1551 1547 1549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 1589 1593 1587 1591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">2001</xref>
###xml 1665 1667 1663 1665 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 1715 1720 1713 1718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuD2</italic>
###xml 2077 2081 2075 2079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuB</italic>
###xml 2108 2112 2106 2110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuG</italic>
###xml 2293 2295 2291 2293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 2328 2337 2326 2335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 24 33 <span type="species:ncbi:1280">S. aureus</span>
###xml 157 166 <span type="species:ncbi:1280">S. aureus</span>
###xml 572 581 <span type="species:ncbi:1280">S. aureus</span>
###xml 2328 2337 <span type="species:ncbi:1280">S. aureus</span>
The transport system of S. aureus for Fe3+-hydroxamates has been characterized without the use of sideromycins (Sebulsky et al. 2003; Speziali et al. 2006). S. aureus grows on simple defined media, which allow addition of Fe3+-siderophores as the sole iron source. The transport system exhibits broad substrate specificity and takes up ferrichrome and the Fe3+-complexes of aerobactin, coprogen, Desferal(R), and rhodotorulic acid. Five involved genes have been identified, four of which are required to promote growth by ferrichrome on iron-limited medium. The genome of S. aureus contains two fhuD genes, which are located distant from the fhuBCG genes (Fig. 3). Both fhuD genes encode substrate-binding proteins that are anchored by an N-terminal lipid to the cytoplasmic membrane. Mutant H430 fhuD1 is sensitive to salmycin and albomycin and transports ferrioxamine and ferrichrome at rates similar to the wild-type. Mutant H364 fhuD2 transports ferrioxamine B with only 10% of the wild-type rate and is nearly salmycin resistant; in contrast, the ferrichrome transport rate is 20% of the wild-type rate, which is sufficient to confer full albomycin sensitivity (Gwinner and Braun, unpublished results). Mutant H431 fhuD1 fhuD2 does not transport either siderophore and is resistant to both antibiotics. The fhuD2 mutant has a lower growth response to ferrichrome and ferrioxamine B than the fhuD1 mutant and a narrower specificity, i.e., aerobactin and coprogen do not support growth, in contrast to the fhuD1 mutant, which grows on all four Fe3+-hydroxamates (Sebulsky and Heinrichs 2001). FhuD2 is the preferred binding protein for the antibiotics and the Fe3+-hydroxamates. A spontaneous salmycin-resistant fhuD2 mutant with a mutation that truncates the protein from 302 to 279 residues still confers albomycin sensitivity. Either the C-proximal end is important for salmycin binding or the expression level of the protein is insufficient for salmycin uptake but sufficient for albomycin uptake. Additional spontaneous salmycin-resistant mutants with deletions in the fhuB gene or insertions in the fhuG gene that encode the transport proteins in the cytoplasmic membrane are cross-resistant to albomycin (Gwinner and Braun, unpublished results). These studies demonstrate a single Fe3+-hydroxamate transport system in S. aureus through which ferrichrome, ferrioxamine B, and the structurally related antibiotics albomycin and salmycin are taken up into cells.
###end p 24
###begin title 25
Active transport strongly reduces the minimal inhibitory concentration
###end title 25
###begin p 26
###xml 640 644 640 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1999</xref>
For many antibiotics, the diffusion rate across the cell membranes into the cytoplasm is poor. This is frequently a serious problem in antibiotic therapy against especially gram-negative bacteria since the outer membrane reduces permeation to such an extent that the minimal inhibitory concentration required reaches toxic levels. In contrast, for sideromycins, the outer membranes and the cytoplasmic membranes do not serve as permeability barriers, but rather actively contribute to the entry of the antibiotics to their targets in the cytoplasm. Active transport reduces the minimal inhibitory concentrations more than a 100-fold (Braun 1999). This is illustrated by the following examples.
###end p 26
###begin p 27
###xml 38 50 38 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptomyces</italic>
###xml 233 235 233 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.</italic>
###xml 235 241 235 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aureus</italic>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">2000</xref>
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 643 652 643 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 657 664 657 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 814 821 814 821 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 881 883 881 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 821 904 821 904 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28">Sensitivity to albomycin and SB-217452 (albomycin without Fe<sup>3+</sup>-siderophore carrier)</p>
###xml 821 904 821 904 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28">Sensitivity to albomycin and SB-217452 (albomycin without Fe<sup>3+</sup>-siderophore carrier)</p></caption>
###xml 904 913 904 913 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Substrate</th>
###xml 913 927 913 927 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Sensitivity to</th>
###xml 904 927 904 927 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2">Substrate</th><th align="left" colspan="2">Sensitivity to</th></tr>
###xml 927 936 927 936 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Albomycin</th>
###xml 936 945 936 945 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">SB-217452</th>
###xml 927 945 927 945 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Albomycin</th><th align="left">SB-217452</th></tr>
###xml 904 945 904 945 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2">Substrate</th><th align="left" colspan="2">Sensitivity to</th></tr><tr><th align="left">Albomycin</th><th align="left">SB-217452</th></tr></thead>
###xml 968 989 968 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 945 997 945 997 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Seryl-tRNA synthetase (<italic>Staphylococcus aureus</italic>, mouse)</td>
###xml 997 1005 997 1005 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Inactive</td>
###xml 1005 1012 1005 1012 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">8&#160;ng/ml</td>
###xml 945 1012 945 1012 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Seryl-tRNA synthetase (<italic>Staphylococcus aureus</italic>, mouse)</td><td align="left">Inactive</td><td align="left">8&#160;ng/ml</td></tr>
###xml 1012 1033 1012 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 1033 1034 1033 1034 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1012 1034 1012 1034 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Staphylococcus aureus</italic><sup>a</sup></td>
###xml 1034 1041 1034 1041 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">8&#160;ng/ml</td>
###xml 1041 1051 1041 1050 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">256&#160;&#956;g/ml</td>
###xml 1012 1051 1012 1050 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Staphylococcus aureus</italic><sup>a</sup></td><td align="left">8&#160;ng/ml</td><td align="left">256&#160;&#956;g/ml</td></tr>
###xml 1051 1067 1050 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 1067 1068 1066 1067 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1051 1068 1050 1067 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Escherichia coli</italic><sup>a</sup></td>
###xml 1068 1075 1067 1074 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">8&#160;ng/ml</td>
###xml 1075 1085 1074 1083 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">256&#160;&#956;g/ml</td>
###xml 1051 1085 1050 1083 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Escherichia coli</italic><sup>a</sup></td><td align="left">8&#160;ng/ml</td><td align="left">256&#160;&#956;g/ml</td></tr>
###xml 1085 1107 1083 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pyogenes</italic>
###xml 1107 1108 1105 1106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1085 1108 1083 1106 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Streptococcus pyogenes</italic><sup>a</sup></td>
###xml 1108 1115 1106 1113 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">8&#160;ng/ml</td>
###xml 1115 1124 1113 1121 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">16&#160;&#956;g/ml</td>
###xml 1085 1124 1083 1121 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Streptococcus pyogenes</italic><sup>a</sup></td><td align="left">8&#160;ng/ml</td><td align="left">16&#160;&#956;g/ml</td></tr>
###xml 1124 1145 1121 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Moraxella catarrhalis</italic>
###xml 1145 1146 1142 1143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1124 1146 1121 1143 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Moraxella catarrhalis</italic><sup>a</sup></td>
###xml 1146 1153 1143 1150 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">8&#160;ng/ml</td>
###xml 1153 1161 1150 1157 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">8&#160;&#956;g/ml</td>
###xml 1124 1161 1121 1157 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Moraxella catarrhalis</italic><sup>a</sup></td><td align="left">8&#160;ng/ml</td><td align="left">8&#160;&#956;g/ml</td></tr>
###xml 945 1161 945 1157 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">Seryl-tRNA synthetase (<italic>Staphylococcus aureus</italic>, mouse)</td><td align="left">Inactive</td><td align="left">8&#160;ng/ml</td></tr><tr><td align="left"><italic>Staphylococcus aureus</italic><sup>a</sup></td><td align="left">8&#160;ng/ml</td><td align="left">256&#160;&#956;g/ml</td></tr><tr><td align="left"><italic>Escherichia coli</italic><sup>a</sup></td><td align="left">8&#160;ng/ml</td><td align="left">256&#160;&#956;g/ml</td></tr><tr><td align="left"><italic>Streptococcus pyogenes</italic><sup>a</sup></td><td align="left">8&#160;ng/ml</td><td align="left">16&#160;&#956;g/ml</td></tr><tr><td align="left"><italic>Moraxella catarrhalis</italic><sup>a</sup></td><td align="left">8&#160;ng/ml</td><td align="left">8&#160;&#956;g/ml</td></tr></tbody>
###xml 904 1161 904 1157 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Substrate</th><th align="left" colspan="2">Sensitivity to</th></tr><tr><th align="left">Albomycin</th><th align="left">SB-217452</th></tr></thead><tbody><tr><td align="left">Seryl-tRNA synthetase (<italic>Staphylococcus aureus</italic>, mouse)</td><td align="left">Inactive</td><td align="left">8&#160;ng/ml</td></tr><tr><td align="left"><italic>Staphylococcus aureus</italic><sup>a</sup></td><td align="left">8&#160;ng/ml</td><td align="left">256&#160;&#956;g/ml</td></tr><tr><td align="left"><italic>Escherichia coli</italic><sup>a</sup></td><td align="left">8&#160;ng/ml</td><td align="left">256&#160;&#956;g/ml</td></tr><tr><td align="left"><italic>Streptococcus pyogenes</italic><sup>a</sup></td><td align="left">8&#160;ng/ml</td><td align="left">16&#160;&#956;g/ml</td></tr><tr><td align="left"><italic>Moraxella catarrhalis</italic><sup>a</sup></td><td align="left">8&#160;ng/ml</td><td align="left">8&#160;&#956;g/ml</td></tr></tbody></table>
###xml 1161 1162 1157 1158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1203 1207 1199 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">2000</xref>
###xml 1161 1244 1157 1240 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="29"><sup>a</sup>Whole cells. Data from Stefanska et al. (<xref ref-type="bibr" rid="CR33">2000</xref>) and Gwinner and Braun (unpublished)</p>
###xml 1161 1244 1157 1240 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="29"><sup>a</sup>Whole cells. Data from Stefanska et al. (<xref ref-type="bibr" rid="CR33">2000</xref>) and Gwinner and Braun (unpublished)</p></table-wrap-foot>
###xml 814 1244 814 1240 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="28">Sensitivity to albomycin and SB-217452 (albomycin without Fe<sup>3+</sup>-siderophore carrier)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Substrate</th><th align="left" colspan="2">Sensitivity to</th></tr><tr><th align="left">Albomycin</th><th align="left">SB-217452</th></tr></thead><tbody><tr><td align="left">Seryl-tRNA synthetase (<italic>Staphylococcus aureus</italic>, mouse)</td><td align="left">Inactive</td><td align="left">8&#160;ng/ml</td></tr><tr><td align="left"><italic>Staphylococcus aureus</italic><sup>a</sup></td><td align="left">8&#160;ng/ml</td><td align="left">256&#160;&#956;g/ml</td></tr><tr><td align="left"><italic>Escherichia coli</italic><sup>a</sup></td><td align="left">8&#160;ng/ml</td><td align="left">256&#160;&#956;g/ml</td></tr><tr><td align="left"><italic>Streptococcus pyogenes</italic><sup>a</sup></td><td align="left">8&#160;ng/ml</td><td align="left">16&#160;&#956;g/ml</td></tr><tr><td align="left"><italic>Moraxella catarrhalis</italic><sup>a</sup></td><td align="left">8&#160;ng/ml</td><td align="left">8&#160;&#956;g/ml</td></tr></tbody></table><table-wrap-foot><p textid="29"><sup>a</sup>Whole cells. Data from Stefanska et al. (<xref ref-type="bibr" rid="CR33">2000</xref>) and Gwinner and Braun (unpublished)</p></table-wrap-foot></table-wrap>
###xml 233 241 <span type="species:ncbi:1280">S.aureus</span>
###xml 246 250 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 643 652 <span type="species:ncbi:1280">S. aureus</span>
###xml 657 664 <span type="species:ncbi:562">E. coli</span>
###xml 968 989 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 991 996 <span type="species:ncbi:10090">mouse</span>
In a screening for new antibiotics in Streptomyces species, the seryl thioribosyl pyrimidine moiety of albomycin free of the siderophore (designated SB-217452) was isolated and shown to inhibit in vitro the seryl-tRNA synthetases of S.aureus and rats (Stefanska et al. 2000). SB-217452 structurally resembles seryl adenylate, which explains the inhibition of seryl-tRNA synthetases. The high in vitro activity against isolated seryl-t-RNA synthetase (Table 1) conflicts with the poor in vivo activity against gram-positive and gram-negative bacteria. Without a siderophore carrier, the antibiotic moiety is 30,0000-fold less effective against S. aureus and E. coli because it barely enters these cells. Other bacteria are somewhat more sensitive to SB-217452, but still 1,000-fold less sensitive than to albomycin.Table 1Sensitivity to albomycin and SB-217452 (albomycin without Fe3+-siderophore carrier)SubstrateSensitivity toAlbomycinSB-217452Seryl-tRNA synthetase (Staphylococcus aureus, mouse)Inactive8 ng/mlStaphylococcus aureusa8 ng/ml256 mug/mlEscherichia colia8 ng/ml256 mug/mlStreptococcus pyogenesa8 ng/ml16 mug/mlMoraxella catarrhalisa8 ng/ml8 mug/mlaWhole cells. Data from Stefanska et al. (2000) and Gwinner and Braun (unpublished)
###end p 27
###begin p 28
###xml 60 62 60 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
Sensitivity to albomycin and SB-217452 (albomycin without Fe3+-siderophore carrier)
###end p 28
###begin p 29
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 42 46 42 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">2000</xref>
aWhole cells. Data from Stefanska et al. (2000) and Gwinner and Braun (unpublished)
###end p 29
###begin p 30
###xml 108 115 108 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 120 130 120 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Salmonella</italic>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">1987</xref>
###xml 878 887 878 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 907 911 907 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">1967</xref>
###xml 926 930 926 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">2007</xref>
###xml 108 115 <span type="species:ncbi:562">E. coli</span>
###xml 878 887 <span type="species:ncbi:1280">S. aureus</span>
Another example is the semi-synthetic rifamycin derivative CGP 4832, which is >200-fold more active against E. coli and Salmonella than rifamycin. The enhanced activity of CGP 4832 rests on transport by the FhuA transporter across the outer membrane into the periplasm (Pugsley et al. 1987). Energy-coupled transport results in an accumulation in the periplasm, which accelerates diffusion across the cytoplasmic membrane, giving rise to an increased cytoplasmic concentration. The higher efficacy of CGP 4832 is not caused by a stronger inhibition of the DNA-dependent RNA polymerase than rifamycin. Ferrimycin A1 and danomycin are other sideromycins derived from ferrioxamine B that are taken up by the ferrioxamine B transport system. Ferrimycin A1 specifically inhibits protein synthesis, as has been shown by incorporation of radiolabeled phenylalanine into whole cells of S. aureus (Nuesch and Knusel 1967; Urban et al. 2007).
###end p 30
###begin p 31
###xml 30 32 30 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 80 82 80 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 202 204 202 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2002</xref>
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">2007</xref>
###xml 322 323 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 347 348 347 348 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 411 412 408 409 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 443 447 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">2004</xref>
###xml 540 547 537 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 636 638 633 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 676 683 673 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 883 890 880 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 966 974 961 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fepA fiu</italic>
###xml 1020 1032 1015 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fepA fiu cir</italic>
###xml 1096 1100 1091 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tonB</italic>
###xml 1175 1180 1170 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">exbBD</italic>
###xml 1348 1352 1343 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">1993</xref>
###xml 540 547 <span type="species:ncbi:562">E. coli</span>
###xml 676 683 <span type="species:ncbi:562">E. coli</span>
###xml 883 892 <span type="species:ncbi:37762">E. coli B</span>
Besides sideromycins of the Fe3+-hydroxamate type, natural sideromyins of the Fe3+-catecholate type occur. Microcins, for example, are antibacterial peptides, some of which are modified covalently by Fe3+-catecholates (Braun et al. 2002; Miethke and Marahiel 2007). In microcin MccE492m (m = modified), a linear trimer of N-(2,3-dihydroxybenzoyl)-l-serine (DHBS) is bound to the C-terminal serine 84 via a beta-d-glucose linker (Thomas et al. 2004). DHBS is the precursor of the cyclic trimer enterobactin, which is a potent siderophore of E. coli and related bacteria. The DHBS monomer, dimer, and trimer also bind iron and serve as Fe3+-siderophores. They are taken up into E. coli via the FepA, Fiu, and Cir outer membrane transporters. These transporters are also required to confer high sensitivity to MccE492m. The minimal inhibitory concentration of MccE492m required to kill E. coli B is 0.04 muM, whereas 0.3 muM is required for the unmodified MccE492. The fepA fiu double mutant exhibits an eight-fold and the fepA fiu cir triple mutant a 200-fold reduction in sensitivity to MccE492m. tonB mutants show a strong reduction in sensitivity, whereas, unexpectedly, an exbBD deletion mutant is unaffected. This is a surprising result because TonB requires ExbBD to function. Since ExbBD can be partially replaced by TolQR (Braun and Herrmann 1993), it would be worthwile to study the TolQR dependence of MccE492m uptake.
###end p 31
###begin p 32
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1999</xref>
###xml 233 235 233 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 271 273 271 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 326 333 326 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 338 360 338 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas aeruginosa</italic>
###xml 624 631 624 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 637 639 637 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 715 720 715 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tonB,</italic>
###xml 897 901 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">1987</xref>
###xml 917 921 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">1988</xref>
###xml 937 941 937 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">1990</xref>
###xml 1016 1018 1016 1018 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 326 333 <span type="species:ncbi:562">E. coli</span>
###xml 338 360 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 624 631 <span type="species:ncbi:562">E. coli</span>
A number of catechol-derived antibiotic conjugates that confer 100-10,000-fold higher antibiotic activity than the antibiotic without iron carrier have been chemically synthesized (compiled in Braun 1999). Cephalosporins linked to Fe3+-catecholates are taken up by the Fe3+-catechol transporters across the outer membranes of E. coli and Pseudomonas aeruginosa, and their activity exceeds that of the unsubstituted cephalosporins by several orders of magnitude. Since cephalosporins inhibit cross-linking of murein (peptidoglycan) in the periplasm, they must be transported only across the outer membrane. Susceptibility of E. coli to Fe3+-catechol cephalosporins is decreased more than 1,000-fold by a mutation in tonB, which is required for active transport, and 100-1,000-fold in mutants that lack two or three of the catecholate outer membrane transporters FepA, Fiu, and Cir (Watanabe et al. 1987; Curtis et al. 1988; Silley et al. 1990). For high efficacy of the conjugates, iron must be present to form the Fe3+-complexes, but the iron concentration must be low to de-repress transcription of the transport genes in the strains tested. Such conditions occur at sites of infections in mammals.
###end p 32
###begin p 33
###xml 11 13 11 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 188 190 188 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 456 460 456 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tonB</italic>
###xml 507 511 507 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tonB</italic>
###xml 569 571 569 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 614 618 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tonB</italic>
###xml 724 728 724 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">2007</xref>
###xml 745 749 745 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR39">2007</xref>
When the Fe3+-siderophore conjugates are transported by a single outer membrane protein, resistant bacteria frequently develop. Such mutants show a reduced growth rate if the particular Fe3+-siderophore transport system is needed at the site of infection or at the location in the environment. Slower growth of pathogenic bacteria would increase the chance of the native and the acquired immune systems to cope with the infection. This also holds true for tonB mutants because many bacteria encode only one tonB gene, and this gene is essential for the uptake of all Fe3+-siderophores and heme. When more than one tonB gene is encoded, the TonB proteins display specificity for certain iron transport systems (Cescau et al. 2007; Wyckoff et al. 2007).
###end p 33
###begin p 34
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">1996</xref>
###xml 296 309 293 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Acinetobacter</italic>
###xml 484 491 479 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 496 509 491 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. aeruginosa</italic>
###xml 484 491 <span type="species:ncbi:562">E. coli</span>
###xml 496 509 <span type="species:ncbi:287">P. aeruginosa</span>
To overcome the resistance problem, a cephalosporin was chemically conjugated to hydroxamates and catecholates that use different transporters (Ghosh et al. 1996). The mixed-ligand siderophore-beta-lactam conjugates are less active than the cephalosporin, except for one compound, which inhibits Acinetobacter at a much lower concentration (0.03 mug/ml) than cephalosporin (64 mug/ml). Despite the mixed ligand and the lower frequency of double mutants than single mutants, resistant E. coli and P. aeruginosa cells developed on agar plates. Such multiple mutants may be subject to iron starvation, which limits proliferation and pathogenicity in the hosts.
###end p 34
###begin title 35
Activity spectrum of albomycin and salmycin
###end title 35
###begin p 36
###xml 207 214 207 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Proteus</italic>
###xml 227 237 227 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Morganella</italic>
###xml 253 254 253 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 257 264 257 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Proteus</italic>
###xml 269 279 269 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Morganella</italic>
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">2007</xref>
###xml 349 352 349 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhu</italic>
###xml 400 417 400 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Proteus mirabilis</italic>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">2007</xref>
###xml 464 468 464 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2008</xref>
###xml 565 568 565 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhu</italic>
###xml 697 706 697 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 711 724 711 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pneumoniae</italic>
###xml 870 894 870 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus agalactiae</italic>
###xml 986 987 986 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 1005 1017 1005 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hafnia alvei</italic>
###xml 1019 1039 1019 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Citrobacter freundii</italic>
###xml 1061 1084 1061 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica</italic>
###xml 1365 1372 1365 1372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 1394 1398 1394 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">foxA</italic>
###xml 1407 1424 1407 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. enterocolitica</italic>
###xml 1426 1433 1426 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 1469 1473 1469 1473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">foxA</italic>
###xml 1609 1616 1609 1616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 1652 1659 1652 1659 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 1659 1702 1659 1702 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="37">Activity spectrum of albomycin and salmycin</p>
###xml 1659 1702 1659 1702 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="37">Activity spectrum of albomycin and salmycin</p></caption>
###xml 1702 1737 1702 1737 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Pathogenic strains (numbers tested)</th>
###xml 1737 1758 1737 1758 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Albomycin sensitivity</th>
###xml 1758 1778 1758 1778 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Salmycin sensitivity</th>
###xml 1702 1778 1702 1778 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Pathogenic strains (numbers tested)</th><th align="left">Albomycin sensitivity</th><th align="left">Salmycin sensitivity</th></tr>
###xml 1702 1778 1702 1778 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Pathogenic strains (numbers tested)</th><th align="left">Albomycin sensitivity</th><th align="left">Salmycin sensitivity</th></tr></thead>
###xml 1778 1794 1778 1794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 1778 1794 1778 1794 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Escherichia coli</italic></td>
###xml 1794 1795 1794 1795 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 1795 1796 1795 1796 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 1778 1796 1778 1796 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Escherichia coli</italic></td><td align="left">+</td><td align="left">&#8722;</td></tr>
###xml 1796 1815 1796 1815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Serratia marcescens</italic>
###xml 1796 1819 1796 1819 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Serratia marcescens</italic> (3)</td>
###xml 1819 1820 1819 1820 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 1820 1821 1820 1821 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 1796 1821 1796 1821 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Serratia marcescens</italic> (3)</td><td align="left">+</td><td align="left">&#8722;</td></tr>
###xml 1821 1842 1821 1842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Serratia liquefaciens</italic>
###xml 1821 1846 1821 1846 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Serratia liquefaciens</italic> (3)</td>
###xml 1846 1847 1846 1847 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 1847 1848 1847 1848 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 1821 1848 1821 1848 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Serratia liquefaciens</italic> (3)</td><td align="left">+</td><td align="left">&#8722;</td></tr>
###xml 1848 1869 1848 1869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae</italic>
###xml 1848 1873 1848 1873 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Klebsiella pneumoniae</italic> (4)</td>
###xml 1873 1874 1873 1874 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 1874 1877 1874 1875 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8723;</td>
###xml 1848 1877 1848 1875 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Klebsiella pneumoniae</italic> (4)</td><td align="left">+</td><td align="left">&#8723;</td></tr>
###xml 1877 1897 1875 1895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shigella dysenteriae</italic>
###xml 1877 1901 1875 1899 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Shigella dysenteriae</italic> (2)</td>
###xml 1901 1902 1899 1900 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 1902 1903 1900 1901 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 1877 1903 1875 1901 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Shigella dysenteriae</italic> (2)</td><td align="left">+</td><td align="left">&#8722;</td></tr>
###xml 1903 1920 1901 1918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shigella flexneri</italic>
###xml 1903 1924 1901 1922 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Shigella flexneri</italic> (2)</td>
###xml 1924 1925 1922 1923 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 1925 1926 1923 1924 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 1903 1926 1901 1924 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Shigella flexneri</italic> (2)</td><td align="left">+</td><td align="left">&#8722;</td></tr>
###xml 1926 1941 1924 1939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shigella sonnei</italic>
###xml 1926 1945 1924 1943 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Shigella sonnei</italic> (1)</td>
###xml 1945 1946 1943 1944 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 1946 1947 1944 1945 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 1926 1947 1924 1945 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Shigella sonnei</italic> (1)</td><td align="left">+</td><td align="left">&#8722;</td></tr>
###xml 1947 1968 1945 1966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Salmonella heidelberg</italic>
###xml 1947 1975 1945 1973 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Salmonella heidelberg</italic> H1 (1)</td>
###xml 1975 1976 1973 1974 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 1976 1977 1974 1975 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 1947 1977 1945 1975 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Salmonella heidelberg</italic> H1 (1)</td><td align="left">+</td><td align="left">&#8722;</td></tr>
###xml 1977 1999 1975 1997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Salmonella enteritidis</italic>
###xml 1977 2003 1975 2001 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Salmonella enteritidis</italic> (2)</td>
###xml 2003 2004 2001 2002 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 2004 2005 2002 2003 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 1977 2005 1975 2003 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Salmonella enteritidis</italic> (2)</td><td align="left">+</td><td align="left">&#8722;</td></tr>
###xml 2005 2028 2003 2026 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica</italic>
###xml 2005 2032 2003 2030 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Yersinia enterocolitica</italic> (5)</td>
###xml 2032 2033 2030 2031 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 2033 2036 2031 2032 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8723;</td>
###xml 2005 2036 2003 2032 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Yersinia enterocolitica</italic> (5)</td><td align="left">+</td><td align="left">&#8723;</td></tr>
###xml 2036 2053 2032 2049 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Proteus mirabilis</italic>
###xml 2036 2058 2032 2054 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Proteus mirabilis</italic> (19)</td>
###xml 2058 2059 2054 2055 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2059 2060 2055 2056 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2036 2060 2032 2056 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Proteus mirabilis</italic> (19)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr>
###xml 2060 2076 2056 2072 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Proteus vulgaris</italic>
###xml 2060 2080 2056 2076 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Proteus vulgaris</italic> (7)</td>
###xml 2080 2081 2076 2077 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2081 2082 2077 2078 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2060 2082 2056 2078 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Proteus vulgaris</italic> (7)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr>
###xml 2082 2101 2078 2097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Morganella morganii</italic>
###xml 2082 2105 2078 2101 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Morganella morganii</italic> (6)</td>
###xml 2105 2106 2101 2102 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2106 2107 2102 2103 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2082 2107 2078 2103 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Morganella morganii</italic> (6)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr>
###xml 2107 2119 2103 2115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hafnia alvei</italic>
###xml 2107 2119 2103 2115 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Hafnia alvei</italic></td>
###xml 2119 2121 2115 2117 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">ND</td>
###xml 2121 2122 2117 2118 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 2107 2122 2103 2118 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Hafnia alvei</italic></td><td align="left">ND</td><td align="left">+</td></tr>
###xml 2122 2142 2118 2138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Citrobacter freundii</italic>
###xml 2122 2142 2118 2138 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Citrobacter freundii</italic></td>
###xml 2142 2144 2138 2140 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">ND</td>
###xml 2144 2145 2140 2141 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 2122 2145 2118 2141 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Citrobacter freundii</italic></td><td align="left">ND</td><td align="left">+</td></tr>
###xml 2145 2167 2141 2163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas aeruginosa</italic>
###xml 2145 2172 2141 2168 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Pseudomonas aeruginosa</italic> (12)</td>
###xml 2172 2173 2168 2169 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2173 2174 2169 2170 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2145 2174 2141 2170 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Pseudomonas aeruginosa</italic> (12)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr>
###xml 2174 2194 2170 2190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Enterococcus faecium</italic>
###xml 2174 2198 2170 2194 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Enterococcus faecium</italic> (3)</td>
###xml 2198 2199 2194 2195 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2199 2200 2195 2196 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2174 2200 2170 2196 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Enterococcus faecium</italic> (3)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr>
###xml 2200 2221 2196 2217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Enterococcus faecalis</italic>
###xml 2200 2225 2196 2221 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Enterococcus faecalis</italic> (3)</td>
###xml 2225 2226 2221 2222 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2226 2227 2222 2223 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2200 2227 2196 2223 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Enterococcus faecalis</italic> (3)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr>
###xml 2227 2247 2223 2243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Enterobacter cloacae</italic>
###xml 2227 2247 2223 2243 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Enterobacter cloacae</italic></td>
###xml 2247 2249 2243 2245 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">ND</td>
###xml 2249 2250 2245 2246 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 2227 2250 2223 2246 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Enterobacter cloacae</italic></td><td align="left">ND</td><td align="left">+</td></tr>
###xml 2250 2274 2246 2270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pneumoniae</italic>
###xml 2250 2278 2246 2274 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Streptococcus pneumoniae</italic> (5)</td>
###xml 2278 2279 2274 2275 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 2279 2280 2275 2276 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 2250 2280 2246 2276 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Streptococcus pneumoniae</italic> (5)</td><td align="left">+</td><td align="left">+</td></tr>
###xml 2280 2304 2276 2300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus agalactiae</italic>
###xml 2280 2308 2276 2304 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Streptococcus agalactiae</italic> (2)</td>
###xml 2308 2309 2304 2305 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2309 2310 2305 2306 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 2280 2310 2276 2306 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Streptococcus agalactiae</italic> (2)</td><td align="left">&#8722;</td><td align="left">+</td></tr>
###xml 2310 2332 2306 2328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pyogenes</italic>
###xml 2310 2336 2306 2332 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Streptococcus pyogenes</italic> (3)</td>
###xml 2336 2337 2332 2333 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2337 2338 2333 2334 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2310 2338 2306 2334 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Streptococcus pyogenes</italic> (3)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr>
###xml 2338 2364 2334 2360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus epidermidis</italic>
###xml 2338 2368 2334 2364 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Staphylococcus epidermidis</italic> (3)</td>
###xml 2368 2369 2364 2365 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2369 2370 2365 2366 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2338 2370 2334 2366 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Staphylococcus epidermidis</italic> (3)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr>
###xml 2370 2391 2366 2387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 2370 2395 2366 2391 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Staphylococcus aureus</italic> (5)</td>
###xml 2395 2396 2391 2392 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 2396 2397 2392 2393 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 2370 2397 2366 2393 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Staphylococcus aureus</italic> (5)</td><td align="left">+</td><td align="left">+</td></tr>
###xml 2397 2419 2393 2415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Listeria monocytogenes</italic>
###xml 2397 2423 2393 2419 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Listeria monocytogenes</italic> (2)</td>
###xml 2423 2424 2419 2420 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2424 2425 2420 2421 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;</td>
###xml 2397 2425 2393 2421 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Listeria monocytogenes</italic> (2)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr>
###xml 2425 2442 2421 2438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis</italic>
###xml 2425 2446 2421 2442 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Bacillus subtilis</italic> (2)</td>
###xml 2446 2447 2442 2443 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 2447 2448 2443 2444 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 2425 2448 2421 2444 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Bacillus subtilis</italic> (2)</td><td align="left">+</td><td align="left">+</td></tr>
###xml 2448 2471 2444 2467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus carnosus</italic>
###xml 2448 2475 2444 2471 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Staphylococcus carnosus</italic> (1)</td>
###xml 2475 2476 2471 2472 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 2476 2477 2472 2473 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 2448 2477 2444 2473 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Staphylococcus carnosus</italic> (1)</td><td align="left">+</td><td align="left">+</td></tr>
###xml 1778 2477 1778 2473 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left"><italic>Escherichia coli</italic></td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Serratia marcescens</italic> (3)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Serratia liquefaciens</italic> (3)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Klebsiella pneumoniae</italic> (4)</td><td align="left">+</td><td align="left">&#8723;</td></tr><tr><td align="left"><italic>Shigella dysenteriae</italic> (2)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Shigella flexneri</italic> (2)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Shigella sonnei</italic> (1)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Salmonella heidelberg</italic> H1 (1)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Salmonella enteritidis</italic> (2)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Yersinia enterocolitica</italic> (5)</td><td align="left">+</td><td align="left">&#8723;</td></tr><tr><td align="left"><italic>Proteus mirabilis</italic> (19)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Proteus vulgaris</italic> (7)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Morganella morganii</italic> (6)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Hafnia alvei</italic></td><td align="left">ND</td><td align="left">+</td></tr><tr><td align="left"><italic>Citrobacter freundii</italic></td><td align="left">ND</td><td align="left">+</td></tr><tr><td align="left"><italic>Pseudomonas aeruginosa</italic> (12)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Enterococcus faecium</italic> (3)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Enterococcus faecalis</italic> (3)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Enterobacter cloacae</italic></td><td align="left">ND</td><td align="left">+</td></tr><tr><td align="left"><italic>Streptococcus pneumoniae</italic> (5)</td><td align="left">+</td><td align="left">+</td></tr><tr><td align="left"><italic>Streptococcus agalactiae</italic> (2)</td><td align="left">&#8722;</td><td align="left">+</td></tr><tr><td align="left"><italic>Streptococcus pyogenes</italic> (3)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Staphylococcus epidermidis</italic> (3)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Staphylococcus aureus</italic> (5)</td><td align="left">+</td><td align="left">+</td></tr><tr><td align="left"><italic>Listeria monocytogenes</italic> (2)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Bacillus subtilis</italic> (2)</td><td align="left">+</td><td align="left">+</td></tr><tr><td align="left"><italic>Staphylococcus carnosus</italic> (1)</td><td align="left">+</td><td align="left">+</td></tr></tbody>
###xml 1702 2477 1702 2473 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Pathogenic strains (numbers tested)</th><th align="left">Albomycin sensitivity</th><th align="left">Salmycin sensitivity</th></tr></thead><tbody><tr><td align="left"><italic>Escherichia coli</italic></td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Serratia marcescens</italic> (3)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Serratia liquefaciens</italic> (3)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Klebsiella pneumoniae</italic> (4)</td><td align="left">+</td><td align="left">&#8723;</td></tr><tr><td align="left"><italic>Shigella dysenteriae</italic> (2)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Shigella flexneri</italic> (2)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Shigella sonnei</italic> (1)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Salmonella heidelberg</italic> H1 (1)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Salmonella enteritidis</italic> (2)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Yersinia enterocolitica</italic> (5)</td><td align="left">+</td><td align="left">&#8723;</td></tr><tr><td align="left"><italic>Proteus mirabilis</italic> (19)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Proteus vulgaris</italic> (7)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Morganella morganii</italic> (6)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Hafnia alvei</italic></td><td align="left">ND</td><td align="left">+</td></tr><tr><td align="left"><italic>Citrobacter freundii</italic></td><td align="left">ND</td><td align="left">+</td></tr><tr><td align="left"><italic>Pseudomonas aeruginosa</italic> (12)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Enterococcus faecium</italic> (3)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Enterococcus faecalis</italic> (3)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Enterobacter cloacae</italic></td><td align="left">ND</td><td align="left">+</td></tr><tr><td align="left"><italic>Streptococcus pneumoniae</italic> (5)</td><td align="left">+</td><td align="left">+</td></tr><tr><td align="left"><italic>Streptococcus agalactiae</italic> (2)</td><td align="left">&#8722;</td><td align="left">+</td></tr><tr><td align="left"><italic>Streptococcus pyogenes</italic> (3)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Staphylococcus epidermidis</italic> (3)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Staphylococcus aureus</italic> (5)</td><td align="left">+</td><td align="left">+</td></tr><tr><td align="left"><italic>Listeria monocytogenes</italic> (2)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Bacillus subtilis</italic> (2)</td><td align="left">+</td><td align="left">+</td></tr><tr><td align="left"><italic>Staphylococcus carnosus</italic> (1)</td><td align="left">+</td><td align="left">+</td></tr></tbody></table>
###xml 2477 2581 2473 2575 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38">ND, not determined; +, sensitive; &#8722;, insensitive; &#8723;, some strains are sensitive, other strains are not</p>
###xml 2477 2581 2473 2575 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="38">ND, not determined; +, sensitive; &#8722;, insensitive; &#8723;, some strains are sensitive, other strains are not</p></table-wrap-foot>
###xml 1652 2581 1652 2575 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="37">Activity spectrum of albomycin and salmycin</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Pathogenic strains (numbers tested)</th><th align="left">Albomycin sensitivity</th><th align="left">Salmycin sensitivity</th></tr></thead><tbody><tr><td align="left"><italic>Escherichia coli</italic></td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Serratia marcescens</italic> (3)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Serratia liquefaciens</italic> (3)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Klebsiella pneumoniae</italic> (4)</td><td align="left">+</td><td align="left">&#8723;</td></tr><tr><td align="left"><italic>Shigella dysenteriae</italic> (2)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Shigella flexneri</italic> (2)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Shigella sonnei</italic> (1)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Salmonella heidelberg</italic> H1 (1)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Salmonella enteritidis</italic> (2)</td><td align="left">+</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Yersinia enterocolitica</italic> (5)</td><td align="left">+</td><td align="left">&#8723;</td></tr><tr><td align="left"><italic>Proteus mirabilis</italic> (19)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Proteus vulgaris</italic> (7)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Morganella morganii</italic> (6)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Hafnia alvei</italic></td><td align="left">ND</td><td align="left">+</td></tr><tr><td align="left"><italic>Citrobacter freundii</italic></td><td align="left">ND</td><td align="left">+</td></tr><tr><td align="left"><italic>Pseudomonas aeruginosa</italic> (12)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Enterococcus faecium</italic> (3)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Enterococcus faecalis</italic> (3)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Enterobacter cloacae</italic></td><td align="left">ND</td><td align="left">+</td></tr><tr><td align="left"><italic>Streptococcus pneumoniae</italic> (5)</td><td align="left">+</td><td align="left">+</td></tr><tr><td align="left"><italic>Streptococcus agalactiae</italic> (2)</td><td align="left">&#8722;</td><td align="left">+</td></tr><tr><td align="left"><italic>Streptococcus pyogenes</italic> (3)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Staphylococcus epidermidis</italic> (3)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Staphylococcus aureus</italic> (5)</td><td align="left">+</td><td align="left">+</td></tr><tr><td align="left"><italic>Listeria monocytogenes</italic> (2)</td><td align="left">&#8722;</td><td align="left">&#8722;</td></tr><tr><td align="left"><italic>Bacillus subtilis</italic> (2)</td><td align="left">+</td><td align="left">+</td></tr><tr><td align="left"><italic>Staphylococcus carnosus</italic> (1)</td><td align="left">+</td><td align="left">+</td></tr></tbody></table><table-wrap-foot><p textid="38">ND, not determined; +, sensitive; &#8722;, insensitive; &#8723;, some strains are sensitive, other strains are not</p></table-wrap-foot></table-wrap>
###xml 400 417 <span type="species:ncbi:584">Proteus mirabilis</span>
###xml 697 706 <span type="species:ncbi:1280">S. aureus</span>
###xml 711 724 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 870 894 <span type="species:ncbi:1311">Streptococcus agalactiae</span>
###xml 1005 1017 <span type="species:ncbi:569">Hafnia alvei</span>
###xml 1019 1039 <span type="species:ncbi:546">Citrobacter freundii</span>
###xml 1061 1084 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 1365 1377 <span type="species:ncbi:83333">E. coli K-12</span>
###xml 1407 1424 <span type="species:ncbi:630">Y. enterocolitica</span>
###xml 1426 1433 <span type="species:ncbi:562">E. coli</span>
###xml 1609 1616 <span type="species:ncbi:562">E. coli</span>
###xml 1796 1815 <span type="species:ncbi:615">Serratia marcescens</span>
###xml 1821 1842 <span type="species:ncbi:614">Serratia liquefaciens</span>
###xml 1848 1869 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
###xml 1877 1897 <span type="species:ncbi:622">Shigella dysenteriae</span>
###xml 1903 1920 <span type="species:ncbi:623">Shigella flexneri</span>
###xml 1926 1941 <span type="species:ncbi:624">Shigella sonnei</span>
###xml 1947 1968 <span type="species:ncbi:611">Salmonella heidelberg</span>
###xml 1977 1999 <span type="species:ncbi:149539">Salmonella enteritidis</span>
###xml 2005 2028 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 2036 2053 <span type="species:ncbi:584">Proteus mirabilis</span>
###xml 2060 2076 <span type="species:ncbi:585">Proteus vulgaris</span>
###xml 2082 2101 <span type="species:ncbi:582">Morganella morganii</span>
###xml 2145 2167 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 2174 2194 <span type="species:ncbi:1352">Enterococcus faecium</span>
###xml 2200 2221 <span type="species:ncbi:1351">Enterococcus faecalis</span>
###xml 2250 2274 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 2280 2304 <span type="species:ncbi:1311">Streptococcus agalactiae</span>
###xml 2310 2332 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
###xml 2338 2364 <span type="species:ncbi:1282">Staphylococcus epidermidis</span>
###xml 2370 2391 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 2397 2419 <span type="species:ncbi:1639">Listeria monocytogenes</span>
###xml 2425 2442 <span type="species:ncbi:1423">Bacillus subtilis</span>
###xml 2448 2471 <span type="species:ncbi:1281">Staphylococcus carnosus</span>
Defined bacterial laboratory strains and clinical isolates have been used to determine growth inhibition by albomycin and salmycin. Albomycin is highly active against gram-negative Enterobacteriaceae except Proteus and related Morganella strains (Table 1). Proteus and Morganella are transport deficient (Pramanik et al. 2007) because they lack the fhu transport genes, as has been shown for several Proteus mirabilis strains (Pramanik et al. 2007; Pearson et al. 2008). This result is unexpected since the genomes of all other tested Enterobacteriaceae encode the fhu transport system. Albomycin kills only a few gram-positive bacteria, among them pathogens of great clinical importance, such as S. aureus and S. pneumoniae. Salmycin displays the same activity spectrum with gram-positive bacteria as albomycin, except that salmycin but not albomycin is active against Streptococcus agalactiae. In contrast to albomycin, salmycin is inactive against most gram-negative bacteria (Table 2). Exceptions are Hafnia alvei, Citrobacter freundii, and some strains of Yersinia enterocolitica, which are sensitive to 10 ng/ml salmycin, the concentration that inhibits gram-positive bacteria. Resistance of the gram-negative bacteria to salmycin is most likely caused by the specificity of the outer membrane transporters, which exclude salmycin. After transformation of an E. coli K-12 strain with the foxA gene of Y. enterocolitica, E. coli becomes sensitive to salmycin. The foxA gene encodes the outer membrane transport protein that takes up ferrioxamine B, the iron carrier of salmycin. This also shows that the E. coli FhuBCD proteins transport salmycin.Table 2Activity spectrum of albomycin and salmycinPathogenic strains (numbers tested)Albomycin sensitivitySalmycin sensitivityEscherichia coli+-Serratia marcescens (3)+-Serratia liquefaciens (3)+-Klebsiella pneumoniae (4)+-/+Shigella dysenteriae (2)+-Shigella flexneri (2)+-Shigella sonnei (1)+-Salmonella heidelberg H1 (1)+-Salmonella enteritidis (2)+-Yersinia enterocolitica (5)+-/+Proteus mirabilis (19)--Proteus vulgaris (7)--Morganella morganii (6)--Hafnia alveiND+Citrobacter freundiiND+Pseudomonas aeruginosa (12)--Enterococcus faecium (3)--Enterococcus faecalis (3)--Enterobacter cloacaeND+Streptococcus pneumoniae (5)++Streptococcus agalactiae (2)-+Streptococcus pyogenes (3)--Staphylococcus epidermidis (3)--Staphylococcus aureus (5)++Listeria monocytogenes (2)--Bacillus subtilis (2)++Staphylococcus carnosus (1)++ND, not determined; +, sensitive; -, insensitive; -/+, some strains are sensitive, other strains are not
###end p 36
###begin p 37
Activity spectrum of albomycin and salmycin
###end p 37
###begin p 38
ND, not determined; +, sensitive; -, insensitive; -/+, some strains are sensitive, other strains are not
###end p 38
###begin p 39
###xml 111 118 111 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 310 312 310 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3+</sup>
###xml 111 118 <span type="species:ncbi:562">E. coli</span>
In general, outer membrane transporters are more specific than cytoplasmic membrane transporters. For example, E. coli transports ferrichrome, aerobactin, and ferrioxamine B by a common transport system across the cytoplasmic membrane but uses specific transporters across the outer membrane for each of the Fe3+-hydroxamates.
###end p 39
###begin title 40
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
In vivo activities of albomycin and salmycin in mouse infection models
###end title 40
###begin p 41
###xml 104 117 104 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pneumoniae</italic>
###xml 151 168 151 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. enterocolitica</italic>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">2007</xref>
###xml 406 419 406 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pneumoniae</italic>
###xml 828 830 828 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink">10</sup>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 104 117 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 151 168 <span type="species:ncbi:630">Y. enterocolitica</span>
###xml 406 419 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 807 811 <span type="species:ncbi:10090">mice</span>
To test the protection by albomycin of mice against infection by pathogenic bacteria, the gram-positive S. pneumoniae strain D39 and the gram-negative Y. enterocolitica strain 8081 serotype O:8 were used; bacterial infection models have been established in these strains (Pramanik et al. 2007). A single dose of 1 mg/kg body weight of intraperitoneally injected albomycin given 12 h post-infection cleared S. pneumoniae administered into the peritoneum of BALBc mice with a lethal dose of 400 colony forming units (CFU). At 7 days post-infection, all albomycin-treated mice had survived and contained no detectable CFU in the blood, liver, and spleen. In an experiment with 10 mg/kg body weight of albomycin administered 8 and 14 h post-infection, 1,000 CFU/ml were found in the blood after 24 h; untreated mice contained 3 x 1010 CFU/ml. The values obtained with albomycin were very similar to the values obtained with amoxicillin.
###end p 41
###begin p 42
###xml 96 98 96 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 104 106 104 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 369 382 369 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pneumoniae</italic>
###xml 283 287 <span type="species:ncbi:10090">Mice</span>
###xml 369 382 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 609 613 <span type="species:ncbi:10090">mice</span>
###xml 726 730 <span type="species:ncbi:10090">mice</span>
###xml 834 838 <span type="species:ncbi:10090">mice</span>
Under laboratory conditions, spontaneous albomycin-resistant bacteria occur at a frequency of 10-4 to 10-5. To examine whether the emergence of resistant bacteria precludes the use of albomycin, growth of an albomycin-resistant strain was compared with growth of a sensitive strain. Mice were infected with a mixture of wild-type (98.6%) and albomycin-resistant (1.4%) S. pneumoniae cells. After 12, 20, 28, and 36 h post-infection, blood was collected from the tail vein, and the number of resistant and sensitive bacteria were determined. At 20 h post-infection, the percentage of mutant cells in untreated mice decreased to 0-0.46% of the total bacterial cells, which indicates that the mutant has a reduced fitness in the mice. At 12 h post-infection, the mutant cells amounted to 0-2% of the total cells in the albomycin-treated mice (5 mg/kg body weight). At 36 h post-infection, the percentage of albomycin-resistant bacteria increased to 86-97%, which indicates eradication of most of the sensitive bacteria and selection for the resistant bacteria.
###end p 42
###begin p 43
###xml 27 44 27 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. enterocolitica</italic>
###xml 80 81 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 645 658 645 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pneumoniae</italic>
###xml 677 678 677 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 910 927 910 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. enterocolitica</italic>
###xml 1018 1022 1018 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">2007</xref>
###xml 1024 1031 1024 1031 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;3</label>
###xml 1056 1073 1056 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. enterocolitica</italic>
###xml 1031 1086 1031 1086 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="44">Development of resistant <italic>Y. enterocolitica</italic> 8081 in mice</p>
###xml 1031 1086 1031 1086 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="44">Development of resistant <italic>Y. enterocolitica</italic> 8081 in mice</p></caption>
###xml 1086 1086 1086 1086 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1086 1102 1086 1102 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Total CFU/spleen</th>
###xml 1102 1115 1102 1115 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Resistant CFU</th>
###xml 1115 1132 1115 1132 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Percent resistant</th>
###xml 1086 1132 1086 1132 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"/><th align="left">Total CFU/spleen</th><th align="left">Resistant CFU</th><th align="left">Percent resistant</th></tr>
###xml 1086 1132 1086 1132 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left"/><th align="left">Total CFU/spleen</th><th align="left">Resistant CFU</th><th align="left">Percent resistant</th></tr></thead>
###xml 1132 1140 1132 1140 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Inoculum</td>
###xml 1146 1147 1146 1147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 1140 1147 1140 1147 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xD7;" align="char">5&#160;&#215;&#160;10<sup>4</sup></td>
###xml 1147 1148 1147 1148 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5</td>
###xml 1148 1152 1148 1152 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.01</td>
###xml 1132 1152 1132 1152 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Inoculum</td><td char="&#215;" align="char">5&#160;&#215;&#160;10<sup>4</sup></td><td align="left">5</td><td char="." align="char">0.01</td></tr>
###xml 1152 1171 1152 1171 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">30&#160;h post-infection</td>
###xml 1179 1180 1179 1180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1171 1180 1171 1180 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xD7;" align="char">3.9&#160;&#215;&#160;10<sup>6</sup></td>
###xml 1180 1181 1180 1181 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0</td>
###xml 1181 1182 1181 1182 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0</td>
###xml 1152 1182 1152 1182 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">30&#160;h post-infection</td><td char="&#215;" align="char">3.9&#160;&#215;&#160;10<sup>6</sup></td><td align="left">0</td><td char="." align="char">0</td></tr>
###xml 1182 1201 1182 1201 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">48&#160;h post-infection</td>
###xml 1209 1210 1209 1210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1201 1210 1201 1210 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xD7;" align="char">4.8&#160;&#215;&#160;10<sup>7</sup></td>
###xml 1210 1213 1210 1213 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">290</td>
###xml 1213 1219 1213 1219 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.0006</td>
###xml 1182 1219 1182 1219 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">48&#160;h post-infection</td><td char="&#215;" align="char">4.8&#160;&#215;&#160;10<sup>7</sup></td><td align="left">290</td><td char="." align="char">0.0006</td></tr>
###xml 1219 1253 1219 1253 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">30&#160;h post-infection with albomycin</td>
###xml 1261 1262 1261 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1253 1262 1253 1262 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xD7;" align="char">7.8&#160;&#215;&#160;10<sup>3</sup></td>
###xml 1262 1264 1262 1264 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">10</td>
###xml 1264 1268 1264 1268 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.13</td>
###xml 1219 1268 1219 1268 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">30&#160;h post-infection with albomycin</td><td char="&#215;" align="char">7.8&#160;&#215;&#160;10<sup>3</sup></td><td align="left">10</td><td char="." align="char">0.13</td></tr>
###xml 1268 1302 1268 1302 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">48&#160;h post-infection with albomycin</td>
###xml 1308 1309 1308 1309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 1302 1309 1302 1309 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xD7;" align="char">8&#160;&#215;&#160;10<sup>4</sup></td>
###xml 1315 1316 1315 1316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1309 1316 1309 1316 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5&#160;&#215;&#160;10<sup>3</sup></td>
###xml 1316 1320 1316 1320 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6.25</td>
###xml 1268 1320 1268 1320 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">48&#160;h post-infection with albomycin</td><td char="&#215;" align="char">8&#160;&#215;&#160;10<sup>4</sup></td><td align="left">5&#160;&#215;&#160;10<sup>3</sup></td><td char="." align="char">6.25</td></tr>
###xml 1132 1320 1132 1320 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">Inoculum</td><td char="&#215;" align="char">5&#160;&#215;&#160;10<sup>4</sup></td><td align="left">5</td><td char="." align="char">0.01</td></tr><tr><td align="left">30&#160;h post-infection</td><td char="&#215;" align="char">3.9&#160;&#215;&#160;10<sup>6</sup></td><td align="left">0</td><td char="." align="char">0</td></tr><tr><td align="left">48&#160;h post-infection</td><td char="&#215;" align="char">4.8&#160;&#215;&#160;10<sup>7</sup></td><td align="left">290</td><td char="." align="char">0.0006</td></tr><tr><td align="left">30&#160;h post-infection with albomycin</td><td char="&#215;" align="char">7.8&#160;&#215;&#160;10<sup>3</sup></td><td align="left">10</td><td char="." align="char">0.13</td></tr><tr><td align="left">48&#160;h post-infection with albomycin</td><td char="&#215;" align="char">8&#160;&#215;&#160;10<sup>4</sup></td><td align="left">5&#160;&#215;&#160;10<sup>3</sup></td><td char="." align="char">6.25</td></tr></tbody>
###xml 1086 1320 1086 1320 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Total CFU/spleen</th><th align="left">Resistant CFU</th><th align="left">Percent resistant</th></tr></thead><tbody><tr><td align="left">Inoculum</td><td char="&#215;" align="char">5&#160;&#215;&#160;10<sup>4</sup></td><td align="left">5</td><td char="." align="char">0.01</td></tr><tr><td align="left">30&#160;h post-infection</td><td char="&#215;" align="char">3.9&#160;&#215;&#160;10<sup>6</sup></td><td align="left">0</td><td char="." align="char">0</td></tr><tr><td align="left">48&#160;h post-infection</td><td char="&#215;" align="char">4.8&#160;&#215;&#160;10<sup>7</sup></td><td align="left">290</td><td char="." align="char">0.0006</td></tr><tr><td align="left">30&#160;h post-infection with albomycin</td><td char="&#215;" align="char">7.8&#160;&#215;&#160;10<sup>3</sup></td><td align="left">10</td><td char="." align="char">0.13</td></tr><tr><td align="left">48&#160;h post-infection with albomycin</td><td char="&#215;" align="char">8&#160;&#215;&#160;10<sup>4</sup></td><td align="left">5&#160;&#215;&#160;10<sup>3</sup></td><td char="." align="char">6.25</td></tr></tbody></table>
###xml 1320 1393 1320 1393 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="45">Albomycin was administered 24&#160;h post-infection. CFU, colony forming units</p>
###xml 1320 1393 1320 1393 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="45">Albomycin was administered 24&#160;h post-infection. CFU, colony forming units</p></table-wrap-foot>
###xml 1024 1393 1024 1393 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table&#160;3</label><caption><p textid="44">Development of resistant <italic>Y. enterocolitica</italic> 8081 in mice</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Total CFU/spleen</th><th align="left">Resistant CFU</th><th align="left">Percent resistant</th></tr></thead><tbody><tr><td align="left">Inoculum</td><td char="&#215;" align="char">5&#160;&#215;&#160;10<sup>4</sup></td><td align="left">5</td><td char="." align="char">0.01</td></tr><tr><td align="left">30&#160;h post-infection</td><td char="&#215;" align="char">3.9&#160;&#215;&#160;10<sup>6</sup></td><td align="left">0</td><td char="." align="char">0</td></tr><tr><td align="left">48&#160;h post-infection</td><td char="&#215;" align="char">4.8&#160;&#215;&#160;10<sup>7</sup></td><td align="left">290</td><td char="." align="char">0.0006</td></tr><tr><td align="left">30&#160;h post-infection with albomycin</td><td char="&#215;" align="char">7.8&#160;&#215;&#160;10<sup>3</sup></td><td align="left">10</td><td char="." align="char">0.13</td></tr><tr><td align="left">48&#160;h post-infection with albomycin</td><td char="&#215;" align="char">8&#160;&#215;&#160;10<sup>4</sup></td><td align="left">5&#160;&#215;&#160;10<sup>3</sup></td><td char="." align="char">6.25</td></tr></tbody></table><table-wrap-foot><p textid="45">Albomycin was administered 24&#160;h post-infection. CFU, colony forming units</p></table-wrap-foot></table-wrap>
###xml 1393 1399 1393 1399 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 1442 1455 1442 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pneumoniae</italic>
###xml 1521 1522 1521 1522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1929 1935 1929 1935 <sub xmlns:xlink="http://www.w3.org/1999/xlink">mutant</sub>
###xml 1979 1985 1979 1985 <sub xmlns:xlink="http://www.w3.org/1999/xlink">mutant</sub>
###xml 2015 2021 2015 2021 <sub xmlns:xlink="http://www.w3.org/1999/xlink">mutant</sub>
###xml 2116 2122 2116 2122 <sub xmlns:xlink="http://www.w3.org/1999/xlink">mutant</sub>
###xml 2202 2208 2202 2208 <sub xmlns:xlink="http://www.w3.org/1999/xlink">mutant</sub>
###xml 1399 2272 1399 2272 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="46">Competitiveness of the albomycin-resistant <italic>S. pneumoniae</italic> mutant D39T1 with the wild-type parent strain D39 in mice. Mice (<italic>n</italic>&#160;=&#160;12) were infected with a mixture of 1,000&#160;CFU of strain D39 and 14&#160;CFU of strain D39T1. After 12&#160;h post-infection, six mice received placebo (PBS) and six mice received albomycin (5&#160;mg/kg body weight, thrice a day). In 8&#160;h intervals, blood samples were collected from the tail vein of each mouse and the bacterial cells were counted. All PBS-treated mice died within 26&#160;h post-infection. Open squares, CI<sub>mutant</sub> from PBS-treated mice; filled triangles, CI<sub>mutant</sub> of albomycin-treated mice. CI<sub>mutant</sub>&#160;=&#160;percentage of mutant CFU in the total CFU/percentage of mutant CFU in the inoculum CFU. A CI<sub>mutant</sub> of 1 indicates that the mutant proliferates as well as the wild-type, and a CFU<sub>mutant</sub> &lt;1 indicates that the mutant multiplies less than the wild-type</p>
###xml 1399 2272 1399 2272 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="46">Competitiveness of the albomycin-resistant <italic>S. pneumoniae</italic> mutant D39T1 with the wild-type parent strain D39 in mice. Mice (<italic>n</italic>&#160;=&#160;12) were infected with a mixture of 1,000&#160;CFU of strain D39 and 14&#160;CFU of strain D39T1. After 12&#160;h post-infection, six mice received placebo (PBS) and six mice received albomycin (5&#160;mg/kg body weight, thrice a day). In 8&#160;h intervals, blood samples were collected from the tail vein of each mouse and the bacterial cells were counted. All PBS-treated mice died within 26&#160;h post-infection. Open squares, CI<sub>mutant</sub> from PBS-treated mice; filled triangles, CI<sub>mutant</sub> of albomycin-treated mice. CI<sub>mutant</sub>&#160;=&#160;percentage of mutant CFU in the total CFU/percentage of mutant CFU in the inoculum CFU. A CI<sub>mutant</sub> of 1 indicates that the mutant proliferates as well as the wild-type, and a CFU<sub>mutant</sub> &lt;1 indicates that the mutant multiplies less than the wild-type</p></caption>
###xml 2272 2272 2272 2272 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10534_2008_9199_Fig4_HTML" id="MO4"/>
###xml 1393 2272 1393 2272 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="46">Competitiveness of the albomycin-resistant <italic>S. pneumoniae</italic> mutant D39T1 with the wild-type parent strain D39 in mice. Mice (<italic>n</italic>&#160;=&#160;12) were infected with a mixture of 1,000&#160;CFU of strain D39 and 14&#160;CFU of strain D39T1. After 12&#160;h post-infection, six mice received placebo (PBS) and six mice received albomycin (5&#160;mg/kg body weight, thrice a day). In 8&#160;h intervals, blood samples were collected from the tail vein of each mouse and the bacterial cells were counted. All PBS-treated mice died within 26&#160;h post-infection. Open squares, CI<sub>mutant</sub> from PBS-treated mice; filled triangles, CI<sub>mutant</sub> of albomycin-treated mice. CI<sub>mutant</sub>&#160;=&#160;percentage of mutant CFU in the total CFU/percentage of mutant CFU in the inoculum CFU. A CI<sub>mutant</sub> of 1 indicates that the mutant proliferates as well as the wild-type, and a CFU<sub>mutant</sub> &lt;1 indicates that the mutant multiplies less than the wild-type</p></caption><graphic position="anchor" xlink:href="10534_2008_9199_Fig4_HTML" id="MO4"/></fig>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 27 44 <span type="species:ncbi:630">Y. enterocolitica</span>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 645 658 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 693 697 <span type="species:ncbi:10090">mice</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
###xml 910 927 <span type="species:ncbi:630">Y. enterocolitica</span>
###xml 1056 1073 <span type="species:ncbi:630">Y. enterocolitica</span>
###xml 1442 1455 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 1509 1513 <span type="species:ncbi:10090">mice</span>
###xml 1515 1519 <span type="species:ncbi:10090">Mice</span>
###xml 1644 1648 <span type="species:ncbi:10090">mice</span>
###xml 1680 1684 <span type="species:ncbi:10090">mice</span>
###xml 1815 1820 <span type="species:ncbi:10090">mouse</span>
###xml 1875 1879 <span type="species:ncbi:10090">mice</span>
###xml 1953 1957 <span type="species:ncbi:10090">mice</span>
###xml 2007 2011 <span type="species:ncbi:10090">mice</span>
Mice are also cleared from Y. enterocolitica by albomycin. An inoculum of 5 x 104 CFU per C57BL/6 mouse yields a strong increase in the number of bacteria in the spleen (Table 3). Administration of albomycin 24 h post-infection strongly reduces the CFU in the spleen. The number of albomycin-resistant bacteria increases in mice treated with albomycin. However, the CFU is nearly 3-4 orders of magnitude lower than in untreated mice, which gives the immune system a chance to cope with the infection. To examine proliferation of resistant bacteria, mice were inoculated with a surplus of sensitive over resistant bacteria. Results obtained with S. pneumoniae are shown in Fig. 4. In untreated mice, more wild-type than mutant bacteria were found in the spleen. In the albomycin-treated mice, the mutant bacteria overrode the wild-type bacteria, which are killed by albomycin. In a similar experiment done with Y. enterocolitica, wild-type bacteria proliferate faster than albomycin-resistant bacteria (Pramanik et al. 2007).Table 3Development of resistant Y. enterocolitica 8081 in miceTotal CFU/spleenResistant CFUPercent resistantInoculum5 x 10450.0130 h post-infection3.9 x 1060048 h post-infection4.8 x 1072900.000630 h post-infection with albomycin7.8 x 103100.1348 h post-infection with albomycin8 x 1045 x 1036.25Albomycin was administered 24 h post-infection. CFU, colony forming unitsFig. 4Competitiveness of the albomycin-resistant S. pneumoniae mutant D39T1 with the wild-type parent strain D39 in mice. Mice (n = 12) were infected with a mixture of 1,000 CFU of strain D39 and 14 CFU of strain D39T1. After 12 h post-infection, six mice received placebo (PBS) and six mice received albomycin (5 mg/kg body weight, thrice a day). In 8 h intervals, blood samples were collected from the tail vein of each mouse and the bacterial cells were counted. All PBS-treated mice died within 26 h post-infection. Open squares, CImutant from PBS-treated mice; filled triangles, CImutant of albomycin-treated mice. CImutant = percentage of mutant CFU in the total CFU/percentage of mutant CFU in the inoculum CFU. A CImutant of 1 indicates that the mutant proliferates as well as the wild-type, and a CFUmutant <1 indicates that the mutant multiplies less than the wild-type
###end p 43
###begin p 44
###xml 25 42 25 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. enterocolitica</italic>
###xml 25 42 <span type="species:ncbi:630">Y. enterocolitica</span>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Development of resistant Y. enterocolitica 8081 in mice
###end p 44
###begin p 45
Albomycin was administered 24 h post-infection. CFU, colony forming units
###end p 45
###begin p 46
###xml 43 56 43 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pneumoniae</italic>
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 530 536 530 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink">mutant</sub>
###xml 580 586 580 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink">mutant</sub>
###xml 616 622 616 622 <sub xmlns:xlink="http://www.w3.org/1999/xlink">mutant</sub>
###xml 717 723 717 723 <sub xmlns:xlink="http://www.w3.org/1999/xlink">mutant</sub>
###xml 803 809 803 809 <sub xmlns:xlink="http://www.w3.org/1999/xlink">mutant</sub>
###xml 43 56 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 116 120 <span type="species:ncbi:10090">Mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 416 421 <span type="species:ncbi:10090">mouse</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
Competitiveness of the albomycin-resistant S. pneumoniae mutant D39T1 with the wild-type parent strain D39 in mice. Mice (n = 12) were infected with a mixture of 1,000 CFU of strain D39 and 14 CFU of strain D39T1. After 12 h post-infection, six mice received placebo (PBS) and six mice received albomycin (5 mg/kg body weight, thrice a day). In 8 h intervals, blood samples were collected from the tail vein of each mouse and the bacterial cells were counted. All PBS-treated mice died within 26 h post-infection. Open squares, CImutant from PBS-treated mice; filled triangles, CImutant of albomycin-treated mice. CImutant = percentage of mutant CFU in the total CFU/percentage of mutant CFU in the inoculum CFU. A CImutant of 1 indicates that the mutant proliferates as well as the wild-type, and a CFUmutant <1 indicates that the mutant multiplies less than the wild-type
###end p 46
###begin p 47
###xml 99 108 99 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8</sup>
###xml 267 276 267 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 382 383 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 562 563 561 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 575 576 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 745 751 744 750 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;5</label>
###xml 812 821 811 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 1059 1060 1058 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1078 1089 1077 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dotted line</italic>
###xml 751 1115 750 1114 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="48">Salmycin treatment of infected mice. Mice were infected with <italic>S. aureus</italic> on day&#160;0, and antibiotics were administered 6 and 24&#160;h post-infection. The bacterial numbers (CFU) were determined in the kidney 72&#160;h post-infection. For comparison, infected mice were treated with a mixture of rifamycin and vancomycin. <italic>n</italic>, number of mice. <italic>Dotted line</italic> indicates detection limit</p>
###xml 751 1115 750 1114 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="48">Salmycin treatment of infected mice. Mice were infected with <italic>S. aureus</italic> on day&#160;0, and antibiotics were administered 6 and 24&#160;h post-infection. The bacterial numbers (CFU) were determined in the kidney 72&#160;h post-infection. For comparison, infected mice were treated with a mixture of rifamycin and vancomycin. <italic>n</italic>, number of mice. <italic>Dotted line</italic> indicates detection limit</p></caption>
###xml 1115 1115 1114 1114 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10534_2008_9199_Fig5_HTML" id="MO5"/>
###xml 745 1115 744 1114 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig5"><label>Fig.&#160;5</label><caption><p textid="48">Salmycin treatment of infected mice. Mice were infected with <italic>S. aureus</italic> on day&#160;0, and antibiotics were administered 6 and 24&#160;h post-infection. The bacterial numbers (CFU) were determined in the kidney 72&#160;h post-infection. For comparison, infected mice were treated with a mixture of rifamycin and vancomycin. <italic>n</italic>, number of mice. <italic>Dotted line</italic> indicates detection limit</p></caption><graphic position="anchor" xlink:href="10534_2008_9199_Fig5_HTML" id="MO5"/></fig>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 99 108 <span type="species:ncbi:1280">S. aureus</span>
###xml 267 276 <span type="species:ncbi:1280">S. aureus</span>
###xml 277 281 <span type="species:ncbi:1280">MRSA</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 782 786 <span type="species:ncbi:10090">mice</span>
###xml 788 792 <span type="species:ncbi:10090">Mice</span>
###xml 812 821 <span type="species:ncbi:1280">S. aureus</span>
###xml 997 1001 <span type="species:ncbi:10090">mice</span>
###xml 1072 1076 <span type="species:ncbi:10090">mice</span>
To examine the in vivo efficacy of salmycin, protection of mice by treatment with salmycin against S. aureus infections (infection dosis: 108 bacterial cells) was tested. Salmycin A (10 mg/kg body weight) administered 6 and 24 h post-infection reduced the CFU of the S. aureus MRSA strain COL in kidneys of CD1 mice 30-fold 48 h post-infection and 80-fold 72 h post-infection (Fig. 5). For comparison, in a control experiment with a mixture of vancomycin and rifamycin (vancomycin alone was ineffective), each at 10 mug/kg body weight, the CFU was reduced 5 x 103- and 2 x 104-fold, respectively. Salmycin A is effective, but should be administered at shorter intervals since it rapidly loses activity. The optimal treatment was not established.Fig. 5Salmycin treatment of infected mice. Mice were infected with S. aureus on day 0, and antibiotics were administered 6 and 24 h post-infection. The bacterial numbers (CFU) were determined in the kidney 72 h post-infection. For comparison, infected mice were treated with a mixture of rifamycin and vancomycin. n, number of mice. Dotted line indicates detection limit
###end p 47
###begin p 48
###xml 61 70 61 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus</italic>
###xml 308 309 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 327 338 327 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dotted line</italic>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 37 41 <span type="species:ncbi:10090">Mice</span>
###xml 61 70 <span type="species:ncbi:1280">S. aureus</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
Salmycin treatment of infected mice. Mice were infected with S. aureus on day 0, and antibiotics were administered 6 and 24 h post-infection. The bacterial numbers (CFU) were determined in the kidney 72 h post-infection. For comparison, infected mice were treated with a mixture of rifamycin and vancomycin. n, number of mice. Dotted line indicates detection limit
###end p 48
###begin p 49
###xml 43 57 43 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus fhuD</italic>
###xml 43 52 <span type="species:ncbi:1280">S. aureus</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
We thank D. E. Heinrichs for providing the S. aureus fhuD mutants; K. A. Brune for critical reading of the manuscript; and the Landesstiftung Baden-Wurtemberg, the Deutsche Forschungsgemeinschaft, and the Fonds der Chemischen Industrie for financial support. Experiments with mice followed animal ethics guidelines under biosafety level containment two in specific pathogen-free facilities.
###end p 49
###begin title 50
References
###end title 50
###begin article-title 51
Active transport of siderophore-mimicking antibacterials across the outer membrane
###end article-title 51
###begin article-title 52
###xml 63 79 63 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 63 79 <span type="species:ncbi:562">Escherichia coli</span>
Evolutionary relationship of uptake systems for biopolymers in Escherichia coli: cross-complementation between the TonB-ExbB-ExbD and the TolA-TolQ-TolR proteins
###end article-title 52
###begin article-title 53
###xml 41 57 41 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 62 84 62 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Salmonella typhimurium</italic>
###xml 41 57 <span type="species:ncbi:562">Escherichia coli</span>
###xml 62 84 <span type="species:ncbi:90371">Salmonella typhimurium</span>
Intracellular activation of albomycin in Escherichia coli and Salmonella typhimurium
###end article-title 53
###begin article-title 54
Ton-dependent colicins and microcins: modular design and evolution
###end article-title 54
###begin article-title 55
###xml 27 51 27 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pneumoniae</italic>
###xml 27 51 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Characterization of Pit, a Streptococcus pneumoniae iron uptake ABC transporter
###end article-title 55
###begin article-title 56
Heme acquisition by hemophores
###end article-title 56
###begin article-title 57
###xml 42 58 42 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 42 63 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Iron-regulated outer membrane proteins of Escherichia coli K-12 and mechanism of action of catechol-substituted cephalosporins
###end article-title 57
###begin article-title 58
Structure, function, and evolution of bacterial ATP-binding cassette systems
###end article-title 58
###begin article-title 59
Crystal structure of the antibiotic albomycin in complex with the outer membrane transporter FhuA
###end article-title 59
###begin article-title 60
Active transport of an antibiotic rifamycin derivative by the outer-membrane protein FhuA
###end article-title 60
###begin article-title 61
Iron transport-mediated drug delivery using mixed-ligand siderophore-beta-lactam conjugates
###end article-title 61
###begin article-title 62
Transmembrane topology of the two FhuB domains representing the hydrophobic components of bacterial ABC transporters involved in the uptake of siderophores, haem and vitamin B12
###end article-title 62
###begin article-title 63
###xml 53 69 53 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 53 74 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Uptake and conversion of the antibiotic albomycin by Escherichia coli K-12
###end article-title 63
###begin article-title 64
Structure and mechanism of ABC transporter proteins
###end article-title 64
###begin article-title 65
Point mutations in two conserved glycine residues within the integral membrane protein FhuB affect iron(III) hydroxamate transport
###end article-title 65
###begin article-title 66
Structural biology of bacterial iron uptake
###end article-title 66
###begin article-title 67
Molecular dynamics simulations of the periplasmic ferric-hydroxamate binding protein FhuD
###end article-title 67
###begin article-title 68
Protonmotive force, ExbB and ligand-bound FepA drive conformational changes in TonB
###end article-title 68
###begin article-title 69
Siderophore-based iron acquisition and pathogen control
###end article-title 69
###begin article-title 70
Sideromycins
###end article-title 70
###begin article-title 71
###xml 42 59 42 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Proteus mirabilis</italic>
###xml 42 59 <span type="species:ncbi:584">Proteus mirabilis</span>
Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility
###end article-title 71
###begin article-title 72
###xml 62 86 62 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pneumoniae</italic>
###xml 62 89 <span type="species:ncbi:171101">Streptococcus pneumoniae R6</span>
Albomycin uptake via a ferric hydroxamate transport system of Streptococcus pneumoniae R6
###end article-title 72
###begin article-title 73
###xml 58 81 58 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia enterocolitica</italic>
###xml 86 110 86 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pneumoniae</italic>
###xml 58 81 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 86 110 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae
###end article-title 73
###begin article-title 74
###xml 94 110 94 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 94 110 <span type="species:ncbi:562">Escherichia coli</span>
Highly efficient uptake of a rifamycin derivative via the FhuA-TonB-dependent uptake route in Escherichia coli
###end article-title 74
###begin article-title 75
###xml 25 41 25 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 25 46 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Ferrichrome transport in Escherichia coli K-12: altered substrate specificity of mutated periplasmic FhuD and interaction of FhuD with the integral membrane protein FhuB
###end article-title 75
###begin article-title 76
Metal trafficking via siderophores in Gram-negative bacteria: specificities and characteristics of the pyoverdine pathway
###end article-title 76
###begin article-title 77
###xml 51 54 51 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cba</italic>
Nucleotide sequence of the colicin B activity gene cba: consensus pentapeptide among TonB-dependent colicins and receptors
###end article-title 77
###begin article-title 78
###xml 35 51 35 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuC</italic>
###xml 35 56 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Iron(III) hydroxamate transport in Escherichia coli K-12: FhuB-mediated membrane association of the FhuC protein and negative complementation of fhuC mutants
###end article-title 78
###begin article-title 79
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuD1</italic>
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fhuD2</italic>
###xml 105 126 105 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 105 126 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Identification and characterization of fhuD1 and fhuD2, two genes involved in iron-hydroxamate uptake in Staphylococcus aureus
###end article-title 79
###begin article-title 80
###xml 56 77 56 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 56 77 <span type="species:ncbi:1280">Staphylococcus aureus</span>
The role of FhuD2 in iron(III)-hydroxamate transport in Staphylococcus aureus: demonstration that FhuD2 binds iron(III)-hydroxamates but with minimal conformational change and implication of mutations on transport
###end article-title 80
###begin article-title 81
Mode of action of GR69153, a novel catechol-substituted cephalosporin, and its interaction with the TonB-dependent iron transport system
###end article-title 81
###begin article-title 82
###xml 15 36 15 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 15 36 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Requirement of Staphylococcus aureus ATP-binding cassette-ATPase FhuC for iron-restricted growth and evidence that it functions with more than one iron transporter
###end article-title 82
###begin article-title 83
###xml 67 79 67 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptomyces</italic>
A potent seryl tRNA synthetase inhibitor SB-217452 isolated from a Streptomyces species
###end article-title 83
###begin article-title 84
Siderophore peptide, a new type of post-translationally modified antibacterial peptide with potent activity
###end article-title 84
###begin article-title 85
Novel whole-cell antibiotic biosensors for compound discovery
###end article-title 85
###begin article-title 86
###xml 30 52 30 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptomyces violaceus</italic>
###xml 30 52 <span type="species:ncbi:1936">Streptomyces violaceus</span>
Salmycin A-D, Antibiotika aus Streptomyces violaceus, DSM 8286, mit Siderophor-Aminoglycosid-Struktur
###end article-title 86
###begin article-title 87
###xml 50 66 50 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 50 66 <span type="species:ncbi:562">Escherichia coli</span>
E-0702, a new cephalosporin, is incorporated into Escherichia coli cells via the TonB-dependent iron transport system
###end article-title 87
###begin article-title 88
TonB-dependent outer membrane transport: going for Baroque?
###end article-title 88
###begin article-title 89
###xml 20 35 20 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vibrio cholerae</italic>
###xml 20 35 <span type="species:ncbi:666">Vibrio cholerae</span>
Iron acquisition in Vibrio cholerae
###end article-title 89

